Use these links to rapidly review the document
TABLE OF CONTENTS

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.    )

Filed by the Registrant ý

Filed by a Party other than the Registrant o

Check the appropriate box:

o

 

Preliminary Proxy Statement

o

 

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

ý

 

Definitive Proxy Statement

o

 

Definitive Additional Materials

o

 

Soliciting Material under §240.14a-12

 

Overstock.com, Inc.

(Name of Registrant as Specified In Its Charter)

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

ý

 

No fee required.

o

 

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
    (1)   Title of each class of securities to which transaction applies:
        
 
    (2)   Aggregate number of securities to which transaction applies:
        
 
    (3)   Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
        
 
    (4)   Proposed maximum aggregate value of transaction:
        
 
    (5)   Total fee paid:
        
 

o

 

Fee paid previously with preliminary materials.

o

 

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

 

(1)

 

Amount Previously Paid:
        
 
    (2)   Form, Schedule or Registration Statement No.:
        
 
    (3)   Filing Party:
        
 
    (4)   Date Filed:
        
 

Table of Contents

LOGO

799 W. Coliseum Way
Midvale, Utah 84047

NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held at 1:00 p.m. on May 9, 2017

Dear Fellow Stockholders:

        We cordially invite you to attend the 2017 Annual Meeting of Stockholders of Overstock.com, Inc. (the "Company"). The meeting will be held at the offices of the Company, located at 799 W. Coliseum Way, Midvale, Utah, at 1:00 p.m. Mountain Time on May 9, 2017. At the meeting, holders of our common stock, our Blockchain Voting Series A Preferred Stock and our Voting Series B Preferred Stock (collectively, our "Voting Shares") will vote on the following matters:

        Stockholders will also consider and act upon any other matter properly coming before the Annual Meeting.

        Following the meeting, we will discuss the status of the business and answer appropriate questions.

        Holders of record of shares of our Voting Shares at the close of business on March 13, 2017 are entitled to vote at the meeting and any postponements or adjournments. To ensure that your vote is recorded promptly, please vote as soon as possible, even if you plan to attend the meeting in person. We encourage you to vote via the Internet or by telephone. If you received a printed set of proxy materials, you also have the option of voting by completing, signing, dating and returning the proxy card that accompanied the printed materials. Submitting your vote via the Internet or by telephone or proxy card will not affect your right to vote in person if you decide to attend the annual meeting.

        We are mailing to some of our stockholders a notice of Internet availability of proxy materials instead of a paper copy of this proxy statement and our Annual Report on Form 10-K for the year ended December 31, 2016 (the "2016 Form 10-K"). The notice contains instructions on how to access those documents via the Internet. The notice also contains instructions on how to request a paper copy of our proxy materials, including this proxy statement, our 2016 Form 10-K and a form of proxy card or voting instruction card, as applicable. Stockholders who do not receive a notice of Internet availability


Table of Contents

of proxy materials will receive a paper copy of the proxy materials by mail. We anticipate that this process will minimize the costs of printing and distributing our proxy materials.

    By Order of the Board of Directors,

 

 

GRAPHIC

Jonathan E. Johnson III
Chairman of the Board

Midvale, Utah
March 14, 2017

Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting of Stockholders to be held on May 9, 2017

The Notice of Annual Meeting, Proxy Statement, and Annual Report on Form 10-K for the fiscal year ended
December 31, 2016 are available at
http://www.overstock.com/proxy.

Whether or not you plan to attend the meeting, please vote via the Internet or by phone or by completing,
signing, dating and returning the accompanying Proxy Card in the enclosed self-addressed, stamped
envelope.


Table of Contents

OVERSTOCK.COM, INC.
799 W. Coliseum Way
Midvale, Utah 84047

PROXY STATEMENT
ANNUAL MEETING OF STOCKHOLDERS

To Be Held at 1:00 p.m. on May 9, 2017

        Our Board of Directors (the "Board") is soliciting proxies for the 2017 Annual Meeting of Stockholders of Overstock.com, Inc. ("Overstock," the "Company," "we" or "our") to be held at the offices of the Company, located at 799 W. Coliseum Way, Midvale, Utah, at 1:00 p.m. Mountain Time on May 9, 2017. This Proxy Statement contains important information for you to consider when deciding how to vote on the matters before the meeting.

        We have elected to provide access to our proxy materials to our stockholders via the Internet. Accordingly, a notice of Internet availability of proxy materials has been mailed to the majority of our stockholders, while other stockholders have instead received paper copies of the proxy materials accessible via the Internet. Stockholders who received the notice of Internet availability of proxy materials have the ability to access the proxy materials at http://www.overstock.com/proxy or request that a printed set of the proxy materials be sent to them by following the instructions set forth on the notice of Internet availability of proxy materials.

        Please visit http://www.overstock.com/proxy for details on how to instruct us to send future proxy materials to you electronically by e-mail or in printed form by mail. If you choose to receive future proxy materials by e-mail, you will receive an e-mail next year with instructions containing a link to those materials or a link to a special website to access our proxy materials. Your election to receive proxy materials by e-mail or printed form by mail will remain in effect until you terminate it.

        Choosing to receive future proxy materials by e-mail will allow us to provide you with the proxy materials you need in a timelier manner and will save us the cost of printing and mailing documents to you.

        Our principal offices are located at 799 W. Coliseum Way, Midvale, Utah 84047, and our telephone number is (801) 947-3100.

        The Board set March 13, 2017 as the record date for the meeting. Stockholders who owned shares of our common stock, our Blockchain Voting Series A Preferred Stock and our Voting Series B Preferred Stock (collectively, our "Voting Shares") at the close of business on that date are entitled to attend and vote at the meeting. Each share is entitled to one vote. There were 25,591,103 Voting Shares outstanding on the record date. A majority of the outstanding Voting Shares present at the meeting in person or by proxy will constitute a quorum for the transaction of business.

        Voting materials, which include this Proxy Statement, the proxy card and our Annual Report on Form 10-K for the year ended December 31, 2016 (the "2016 Form 10-K"), are first being sent or given to stockholders on or about March 23, 2017.

The date of this Proxy Statement is March 14, 2017.

1


Table of Contents


TABLE OF CONTENTS

PROXY STATEMENT

    1  

QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING AND PROCEDURAL MATTERS

   
4
 

PROPOSALS TO BE VOTED ON:

   
10
 

PROPOSAL 1—ELECTION OF DIRECTORS

   
10
 

PROPOSAL 2—RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

    10  

PROPOSAL 3—VOTE ON AMENDMENT AND RESTATEMENT OF OUR 2005 EQUITY INCENTIVE PLAN

    12  

PROPOSAL 4—ADVISORY VOTE ON THE COMPENSATION PAID BY THE COMPANY TO ITS NAMED EXECUTIVE OFFICERS ("SAY ON PAY VOTE")

    24  

PROPOSAL 5—ADVISORY VOTE ON THE FREQUENCY (EVERY ONE, TWO OR THREE YEARS) OF FUTURE SAY ON PAY VOTES

    25  

OTHER BUSINESS

    25  

THE BOARD

   
26
 

General

   
26
 

Board Independence

    26  

Committees of the Board

    27  

Board and Committee Meetings

    27  

Board Leadership Structure

    28  

Board Role in Risk Oversight

    28  

Director Qualifications

    28  

Identification and Evaluation of Nominees for Director

    29  

Communications with the Board

    29  

Annual Meeting Attendance

    29  

Code of Ethics

    30  

Policies and Procedures Regarding Related Party Transactions

    30  

Information Regarding Director Nominees and Other Directors

    30  

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

   
34
 

EXECUTIVE COMPENSATION

   
34
 

COMPENSATION DISCUSSION AND ANALYSIS

   
34
 

Introduction

   
34
 

2014 Say on Pay Vote and 2011 Say on When Vote

    35  

Compensation Objectives

    35  

Employment Agreements

    36  

Retirement Benefits

    36  

Role of Compensation Consultants

    36  

Elements of Compensation

    36  

Nonqualified Deferred Compensation Plan

    39  

Executive Compensation Action Taken After Year-End

    39  

Timing of Equity Awards

    40  

Severance and Change of Control Arrangements

    40  

Security Ownership Requirements

    41  

Hedging Policy

    41  

2


Table of Contents

COMPENSATION COMMITTEE REPORT

    41  

Compensation Paid to Executive Officers

   
42
 

SUMMARY COMPENSATION TABLE

   
42
 

GRANTS OF PLAN-BASED AWARDS

   
44
 

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END

   
45
 

OPTION EXERCISES AND STOCK VESTED

   
46
 

Nonqualified Deferred Compensation Plan

   
46
 

NONQUALIFIED DEFERRED COMPENSATION

   
47
 

COMPENSATION OF DIRECTORS

   
47
 

DIRECTOR COMPENSATION TABLE

   
48
 

POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL

   
49
 

EQUITY COMPENSATION PLAN INFORMATION

   
52
 

REPORT OF THE AUDIT COMMITTEE

   
52
 

SHARE OWNERSHIP OF MANAGEMENT, DIRECTORS, NOMINEES AND 5% STOCKHOLDERS

   
54
 

OTHER INFORMATION

   
56
 

Certain Relationships and Related Transactions

   
56
 

Section 16(a) Beneficial Ownership Reporting Compliance

    57  

Procedure for Submitting Stockholder Proposals

    57  

Procedure for Nominating Directors for Election at an Annual Meeting or a Special Meeting

    58  

Costs of Proxy Solicitation

    59  

Householding

    60  

3


Table of Contents

QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING
AND PROCEDURAL MATTERS

What is the purpose of the Annual Meeting?

        At our Annual Meeting, stockholders will act upon the matters outlined in the meeting notice provided with this proxy statement, including:

Who can vote at the Annual Meeting?

        Stockholders of record who owned Overstock common stock, Blockchain Voting Series A Preferred Stock or Voting Series B Preferred Stock (collectively, the "Voting Shares") at the close of business on March 13, 2017 (the "Record Date") may attend and vote at the Annual Meeting. Each Voting Share is entitled to one vote. There were 25,591,103 Voting Shares outstanding at the close of business on the Record Date.

What are the recommendations of the Board?

        Overstock's Board unanimously recommends votes:

        For the ONCE EVERY THREE YEARS choice in the advisory vote on the frequency of future stockholder votes on executive compensation (see proposal 5).

What is a quorum?

        The presence in person or by proxy of the holders of a majority of the Voting Shares outstanding on the Record Date will constitute a quorum for the Annual Meeting. A quorum is necessary to transact business at the meeting. Voting Shares represented by proxies that reflect abstentions or "broker non-votes" (i.e., shares held by a broker or nominee that are represented at the meeting, but with respect to which such broker or nominee is not empowered to vote on a particular proposal) will be counted as present and entitled to vote for purposes of determining the presence of a quorum. The inspector of election will tabulate the proxies and votes cast prior to the meeting and at the meeting to determine whether a quorum is present.

4


Table of Contents

How do I vote?

        You may submit your vote via the Internet, by telephone or in person at the annual meeting. If you received printed proxy materials, you also have the option of submitting your proxy card by mail or attending the meeting and delivering the proxy card. The designated proxies will vote according to your instructions; however, if you are a registered stockholder and you return an executed proxy card without specific instructions on how to vote, the proxies will vote:

        If you are a "street name" stockholder and you do not return instructions on how to vote to your broker, your shares will not be voted except on proposal 2. The voting of shares held by "street name" stockholders is further discussed below. Additionally, in order to vote at the meeting, you will need to obtain a signed proxy from the broker or nominee that holds your shares, because the broker or nominee is the legal, registered owner of the shares. If you have the broker's proxy, you may vote by ballot or you may complete and deliver another proxy card in person at the meeting.

        If you hold Voting Shares in a retirement or savings plan or other similar plan, you may submit your vote via the Internet or by telephone or by means of the direction on the proxy card. The trustee or administrator of the plan will vote according to your directions and the rules of the plan.

What happens if a nominee is unable to stand for election?

        The Nominating and Corporate Governance Committee of the Board of Directors may select a substitute nominee. In that case, if you have submitted your proxy via the Internet or by telephone or completed and returned your proxy card or voting instruction card, the proxy holders will have the discretion to vote your shares for the substitute nominee. They cannot vote for more than two Class III nominees.

Can I vote via the Internet or by telephone?

        You may submit your vote via the Internet or by telephone by following the instructions contained in the notice of Internet availability of proxy materials. If you received a printed set of proxy materials, you may submit your vote via the Internet or by telephone by following the instructions contained on the proxy card that accompanied the printed materials.

        If you are a registered stockholder, the deadline for submitting your vote by telephone or via the Internet is 11:59 p.m. Eastern Time on May 8, 2017. If you are a participant in the Overstock 401(k) plan, the deadline for submitting your voting directions by telephone or via the Internet is 2:00 a.m. Eastern Time on May 5, 2017.

Can I change my vote or revoke my proxy?

        Subject to the deadlines set forth in the paragraph above, you may change your vote at any time before the proxy is exercised by re-submitting your vote via the Internet or by telephone.

        If you are a registered stockholder and have delivered a proxy, you may revoke your proxy at any time before the proxy is exercised by filing with our corporate Secretary a written notice of revocation

5


Table of Contents

at our Company headquarters at the address shown on the first page of this proxy statement. At the meeting, you also may revoke your proxy by submitting a written revocation or a later-dated proxy to the inspector of election. Your attendance at the meeting will not by itself revoke your proxy.

        If your shares are held in "street name" or you are a participant in the Overstock 401(k) plan, please contact your broker, nominee, trustee or administrator to determine whether you will be able to revoke or change your vote.

Why did I receive a notice of Internet availability of proxy materials instead of a full set of the proxy materials?

        The rules of the U.S. Securities and Exchange Commission (the "SEC") allow companies to furnish their proxy materials via the Internet. Accordingly, we sent most of our stockholders a notice of Internet availability of proxy materials for this year's annual meeting of stockholders. Other stockholders were instead sent paper copies of the proxy materials accessible via the Internet. Instructions on how to access the proxy materials via the Internet or to request a paper copy can be found in the notice of Internet availability of proxy materials. In addition, stockholders may request proxy materials in printed form, by mail or electronically by e-mail on an ongoing basis by submitting a request to us at http://www.overstock.com/proxy. A stockholder's election to receive proxy materials by mail or e-mail will remain in effect until the stockholder terminates it.

Can I vote my shares by filling out and returning the notice of Internet availability of proxy materials?

        No, but the notice of Internet availability of proxy materials provides instructions on how to vote your shares.

What is the voting requirement to approve each of the proposals?

        Assuming a quorum is present, the matters to come before the Annual Meeting that are listed in the Notice of Annual Meeting of Stockholders require the votes described below to be approved.

        Proposal 1—Election of Directors—a plurality of the votes cast by the holders of Voting Shares entitled to vote at the Annual Meeting is required to elect each of two Class III members of the Board of Directors. This means that the two nominees receiving the highest numbers of "for" votes will be elected. "Withhold" votes and broker non-votes will have no effect on the election of directors. There is no cumulative voting in the election of directors.

        Proposal 2—Ratification of our Audit Committee's appointment of KPMG LLP as our independent registered public accounting firm—the affirmative vote of the holders of a majority of the shares of Voting Shares present in person or represented by proxy and voting on the matter (which shares voting affirmatively also constitute at least a majority of the required quorum) is required to approve this proposal. Abstentions and broker non-votes will have no effect on the determination of whether this proposal has received the vote of a majority of the Voting Shares present or represented by proxy and voting at the meeting. However, abstentions and broker non-votes could prevent the approval of this proposal if the number of affirmative votes, though a majority of the votes represented and cast, does not constitute a majority of the required quorum.

        Proposal 3—Amendment and Restatement of the Company's Equity Incentive Plan—the affirmative vote of the holders of a majority of the shares of Voting Shares present in person or represented by proxy and voting on the matter (which shares voting affirmatively also constitute at least a majority of the required quorum) is required to approve this proposal. Abstentions and broker non-votes will have no effect on the determination of whether this proposal has received the vote of a majority of the Voting Shares present or represented by proxy and voting at the meeting. However, abstentions and broker non-votes could prevent the approval of this proposal if the number of

6


Table of Contents

affirmative votes, though a majority of the votes represented and cast, does not constitute a majority of the required quorum.

        Proposal 4—Executive Compensation—the affirmative vote of the holders of a majority of the shares of Voting Shares present in person or represented by proxy and voting on the matter (which shares voting affirmatively also constitute at least a majority of the required quorum) is required to approve this proposal. Abstentions and broker non-votes will have no effect on the determination of whether this proposal has received the vote of a majority of the Voting Shares present or represented by proxy and voting at the meeting. However, abstentions and broker non-votes could prevent the approval of this proposal if the number of affirmative votes, though a majority of the votes represented and cast, does not constitute a majority of the required quorum.

        Proposal 5—Frequency of Future Non-Binding Votes on Executive Compensation—the non-binding advisory vote as to Proposal 5 will require stockholders to choose the frequency of every one, two or three years or to abstain from voting on Proposal 5, and the selection receiving the most votes—every one, two or three years—will be the recommendation of the stockholders. Abstentions and broker non-votes will have no effect on Proposal 5.

        Neither the approval nor the disapproval of Proposal 4 or the result of the voting on Proposal 5 will be binding on the Company or the Board of Directors or will be construed as overruling any decision by the Company or the Board of Directors or create or imply any additional fiduciary duties for the Company or the Board of Directors. However, the Board and the Company will consider the results of these advisory votes in making future decisions on the Company's compensation policies, the compensation of the Company's named executive officers, and the frequency of future advisory votes on executive compensation.

What are Broker Non-Votes?

        Stockholders who hold their shares through a broker or other nominee (in "street name"), must provide specific instructions to their brokers or other nominee as to how to vote their shares, in the manner prescribed by their broker or other nominee. Brokers and nominees typically have the discretion to vote such shares on routine matters, but not on non-routine matters. If a broker or nominee has not received voting instructions from an account holder and does not have discretionary authority to vote shares on a particular item because it is a non-routine matter, a "broker non-vote" occurs.

Which proposals are considered "routine" or "non-routine"?

        Only Proposal 2 (the proposed ratification of our independent registered public accounting firm) is considered a routine matter. A broker or other nominee may generally vote in their discretion on routine matters, and therefore no broker non-votes are expected in connection with Proposal No. 2. All of the other proposals are considered non-routine.

How many shares of Series A Preferred, Series B Preferred and Common Stock are outstanding and entitled to vote at the meeting?

        At the Record Date, a total of 25,591,103 Voting Shares were outstanding and entitled to vote at the meeting, consisting of 126,565 shares of Blockchain Voting Series A Preferred Stock ("Series A Preferred"), 569,333 shares of Voting Series B Preferred Stock ("Series B Preferred"), and 24,895,205 shares of Common Stock.

7


Table of Contents

Are any shares entitled to a class vote on any of the proposals to be considered at the meeting?

        None of the outstanding shares are entitled to a separate class vote on any of the proposals to be considered at the meeting. The Series A Preferred, the Series B Preferred and the Common Stock will all vote together as a single class on each of the proposals, and each share will be entitled to one vote on each of the proposals.

How many votes are required to approve other matters that may come before the stockholders at the meeting?

        The affirmative vote of the holders of a majority of the Voting Shares represented and voting at the meeting (which shares voting affirmatively also constitute at least a majority of the required quorum) will be required to approve any other matters that may properly come before the meeting, unless a different vote is required by law, by the Certificate of Incorporation or by the bylaws.

Is my vote kept confidential?

        Proxies, ballots and voting tabulations identifying stockholders are kept confidential and will not be disclosed except as may be necessary to meet legal requirements.

Where do I find the voting results of the meeting?

        We will announce preliminary voting results at the meeting, and will file a Form 8-K with the SEC reporting the results within four business days after the date of the meeting. If required, we will amend that Form 8-K in accordance with Item 5.07(d) of Form 8-K to disclose our decision as to how frequently we will hold a stockholder vote on the compensation of executives within the time periods required by Item 5.07(d). You can get a copy of that Form 8-K by calling Overstock Investor Relations at (801) 947-3100 or the SEC at (800) SEC-0330 for the location of the nearest public reference room, or through the EDGAR system at www.sec.gov. You can also get a copy from our website at http://www.overstock.com/proxy.

Who pays for the proxy solicitation process?

        We will pay the costs of soliciting proxies, including the cost of preparing, posting and mailing proxy materials. In addition to soliciting stockholders by mail, we will request brokers, banks and other nominees to solicit their customers who hold shares of Overstock common stock or Series B Preferred in street name. We may reimburse such brokers, banks and nominees for their reasonable out-of- pocket expenses. We may also use the services of our officers, directors and employees to solicit proxies, personally or by telephone, mail, facsimile or email, without additional compensation other than reimbursement for reasonable out-of-pocket expenses. We intend to use the services of a proxy solicitation firm in connection with the meeting and anticipate that the costs of such services will be approximately $9,500 plus reimbursement for reasonable out-of-pocket expenses.

How can I get an additional copy of the proxy materials?

        If you would like an additional copy of this proxy statement or our 2016 Form 10-K, these documents are available in digital form for download or review at http://www.overstock.com/proxy. Alternatively, we will promptly send a copy to you at no charge upon request by mail to Overstock.com, Inc., Attention: Investor Relations, 799 W. Coliseum Way, Midvale, Utah 84047, or by calling Overstock Investor Relations at (801) 947-3100.

8


Table of Contents

Who can help answer my questions?

        If you have questions about voting or the proposals described in this Proxy Statement, please call Georgeson Inc., our proxy solicitor, toll-free at 866-432-2791.

Important Notice Regarding the Availability of Proxy Materials for the
Annual Meeting of Stockholders to be held on May 9, 2017

The Notice of Annual Meeting, Proxy Statement, and Annual Report on Form 10-K for the fiscal year
ended December 31, 2016 are available at
http://www.overstock.com/proxy.

9


Table of Contents


PROPOSALS TO BE VOTED ON:

PROPOSAL 1—ELECTION OF DIRECTORS

        The nominees for election this year as Class III directors, for three-year terms ending in 2020, are Allison H. Abraham and Saum Noursalehi.

        Ms. Abraham has been a director since 2002. She is the Chair of the Audit Committee, a member of the Compensation Committee, and a member of the Nominating and Corporate Governance Committee.

        Mr. Noursalehi has served as our President, Retail, since August 2016. He joined the Company in 2005 and has served us in several executive positions, including Chief Revenue Officer and Senior Vice President.

        Each of the nominees has consented to serve a three-year term. For additional information about the nominees, see "The Board—Information Regarding Director Nominees and Other Directors."

        The Board of Directors unanimously recommends a vote "FOR" each of the nominees.

PROPOSAL 2—RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

        The Audit Committee of the Board of Directors has appointed KPMG LLP as our independent registered public accounting firm to audit our financial statements for the fiscal year ending December 31, 2017 and audit the effectiveness of our internal control over financial reporting as of December 31, 2017. KPMG LLP has served as our independent registered public accounting firm since December 2009. Although ratification of the Audit Committee's selection of KPMG LLP is not required under our bylaws or other legal requirements, we are submitting the appointment of KPMG LLP to the stockholders as a matter of good corporate practice. If the stockholders do not ratify the appointment of KPMG LLP, the Audit Committee will reconsider whether or not to retain KPMG LLP. Even if the stockholders ratify the selection of KPMG LLP, the Audit Committee may appoint a different independent registered public accounting firm or replace KPMG LLP with a different independent registered public accounting firm at any time if the Audit Committee determines that it is in the best interests of the Company and the stockholders to do so. Representatives of KPMG LLP are expected to attend the annual meeting to respond to appropriate questions and will have an opportunity to make a statement if they so desire.

        KPMG LLP was engaged as our independent registered public accounting firm to audit our financial statements for the years ended December 31, 2016 and 2015, to audit the effectiveness of our internal control over financial reporting as of December 31, 2016 and 2015, to review our 2016 and 2015 interim financial statements, to perform services in connection with our registration statements and SEC comment letter responses, and to perform accounting consultation services. The aggregate audit fees KPMG LLP billed us for professional services for 2016 and 2015 were $1,770,000 and $1,583,000. All audit fees and other fees were pre-approved by the Audit Committee.

10


Table of Contents

        KPMG LLP billed us $30,000 in 2016 and $28,000 in 2015 for the audits of our 401(k) employee benefit plan.

        KPMG LLP billed us $51,272 in 2016 and $27,000 in 2015 for professional services rendered in connection with tax advice.

        KPMG LLP did not bill us any amounts in 2016 or 2015 for other fees.

        The Audit Committee has considered the role of KPMG LLP in providing us with the services described above, and has concluded that those services were compatible with the independence of KPMG LLP from management and from the Company.

General

        The Audit Committee has adopted an Audit and Non-Audit Services Pre-Approval Policy (the "Policy"), which sets forth the procedures and the conditions pursuant to which all services to be performed by the independent registered public accounting firm are required to be pre-approved. Under the Policy, proposed services either may be pre-approved by agreeing to a framework with descriptions of allowable services with the Audit Committee ("general pre-approval"), or require the specific pre-approval of the Audit Committee ("specific pre-approval"). Unless a type of service has received general pre-approval, it requires specific pre-approval by the Audit Committee if it is to be provided by the independent registered public accounting firm.

        The Policy describes the Audit, Audit-related, Tax and All Other Services that are subject to the general pre-approval of the Audit Committee. The Audit Committee annually reviews and pre-approves the services that may be provided by the independent registered public accounting firm that are subject to general pre-approval. Under the Policy, the Audit Committee may delegate either type of pre-approval authority to its chairperson or any other member or members. The member to whom such authority is delegated must report, for informational purposes only, any pre-approval decisions to the Audit Committee at its next meeting. The Policy does not delegate the Audit Committee's responsibilities to pre-approve services performed by the independent registered public accounting firm to management.

Audit Services

        The annual audit services engagement scope and terms are subject to the general pre-approval of the Audit Committee. Audit services include the annual financial statement audit (including required interim reviews performed in accordance with applicable standards) and other procedures required to be performed by the independent registered public accounting firm to be able to form an opinion on our consolidated financial statements. Audit services also include the attestation engagement for the independent registered public accounting firm's audit of the effectiveness of internal control over financial reporting. The Policy provides that the Audit Committee will monitor the audit services engagement throughout the year and will also approve, if necessary, any changes in terms and

11


Table of Contents

conditions resulting from changes in audit scope or other items. The Policy provides for Audit Committee pre-approval of specific audit services outside the engagement scope.

Audit-related Services

        Audit-related services are assurance and related services that are reasonably related to the performance of the audit or review of our financial statements or that are traditionally performed by the independent registered public accounting firm. Under the Policy, the Audit Committee grants general pre-approval for audit-related services.

Tax Services

        Under the Policy, the Audit Committee may grant general pre-approval for specific tax compliance, planning and advice services to be provided by the independent registered public accounting firm, that the Audit Committee has reviewed and believes would not impair the independence of the independent registered public accounting firm, and that are consistent with the SEC's rules on auditor independence. Tax services to be performed by our independent registered public accounting firm must be specifically approved by the Audit Committee.

All Other Services

        Under the Policy, the Audit Committee may grant pre-approval for specific permissible non-audit services classified as All Other Services that it believes are routine and recurring services, would not impair the independence of the independent registered public accounting firm and are consistent with the SEC's rules on auditor independence. Services permissible under applicable rules but not specifically approved in the Policy require further specific pre-approval by the Audit Committee.

Procedures

        Under the Policy, each year the Senior Vice President, Finance and Risk Management (our principal financial and accounting officer) and our independent registered public accounting firm jointly submit to the Audit Committee a schedule of audit, audit-related, tax and other non-audit services that are subject to pre-approval. This schedule provides a description of each type of service that is subject to pre-approval and, where possible, provides projected fees (or a range of projected fees) for each service. The Audit Committee reviews and approves the types of services and reviews the projected fees for the next fiscal year. Any changes to the fee amounts listed in the schedule are subject to further specific approval of the Audit Committee. The Policy prohibits the independent registered public accounting firm from commencing any project not described in the schedule approved by the Audit Committee until specific approval has been given.

        The Board of Directors unanimously recommends that the stockholders vote "FOR" Proposal 2—Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for 2017.

PROPOSAL 3—VOTE ON AMENDMENT AND RESTATEMENT OF OUR 2005 EQUITY INCENTIVE PLAN

        We are asking our stockholders to approve an amendment and restatement of our 2005 Equity Incentive Plan (the "2005 Plan"). However, we are not asking our stockholders to approve any increase of the number of shares available under the 2005 Plan. The proposed amendment will not add any additional shares or otherwise increase the cost of the 2005 Plan.

12


Table of Contents

        The primary purpose of the proposed amendment is to impose limits on the awards we may make to our non-employee directors under the 2005 Plan. As described below, the average total value of the cash and equity grants we have paid to our non-employee directors over the last eight years is approximately $184,000, and the proposed amendment would impose a limit on future awards under the 2005 Plan to any non-employee director in any year so that the awards plus the cash fees payable to such director during such fiscal year for service as an non-employee director may not exceed $400,000 in total value, plus up to an additional $200,000 for service on any special committee of the Board. The text of the proposed amendment is as follows:

        "Awards to any non-employee Director during any Fiscal Year plus the cash fees payable to such Director during such Fiscal Year for service as an non-employee Director shall not exceed $400,000 in total value (calculating the value of any such Awards based on the grant date fair value for financial reporting purposes of such Awards), plus up to an additional $200,000 for service on any special committee of the Board. Consulting fees or other compensation the Company may pay or provide to any non-employee Director for services in addition to the services normally performed by a non-employee Director shall not be included in calculating such limits."

        See "Summary of the Plan—Limitation on Awards to Non-Employee Directors," below. If the proposed amended and restated 2005 Plan is not approved, the proposed limit would not apply.

        In addition, we are asking our stockholders to re-approve the material terms of the 2005 Plan and the performance goals thereunder for the purpose of helping awards under the amended and restated 2005 Plan qualify as "performance-based" compensation under Internal Revenue Code Section 162(m).

        As of February 15, 2017:

        During 2016 we granted restricted stock units covering 540,945 shares of common stock under the 2005 Plan, including 194,586 restricted stock units granted to persons who were executive officers of the Company during 2016. We have not granted any stock options under the 2005 Plan since 2008.

        The amended and restated 2005 Plan provides for the grant of options to purchase shares of our common stock, stock appreciation rights ("SARs"), restricted stock, restricted stock units, performance shares, performance units, and deferred stock units to employees and consultants of the Company. We have never made any awards under the 2005 Plan other than options and grants of restricted stock or restricted stock units. The amendment and restatement does not make any material change to the types of awards that may be granted under the 2005 Plan. Our Board of Directors approved the amended and restated 2005 Plan on March 12, 2017, subject to stockholder approval at the 2017 annual meeting.

        On March 9, 2017, the closing price of our common stock was $17.40 per share. The title of the securities that will be subject to grants under the amended and restated 2005 Plan is our Common Stock, $0.0001 par value per share. The number of shares of common stock that will be subject to grants under the amended and restated 2005 Plan will be 1,978,307, regardless of whether the stockholders approve the proposed amendment, adjusted for any award made or forfeited after February 15, 2017.

13


Table of Contents

        The classes of persons who are currently and would be eligible to participate in the amended and restated Plan and the approximate number of persons in each such class are currently as follows: Non-employee directors (four persons); Named Executive Officers (four persons, as all others have left the Company); executive and other officers excluding the Named Executive Officers (19 persons); employees excluding all executive and other officers (approximately 1,685 persons) and consultants (0 persons). The basis of participation by any person will be the grant of an award by the Compensation Committee or the full Board of Directors. Awards are expected to be made primarily if not exclusively to persons the Compensation Committee believes have the ability to have a significant effect on the success of the Company's business.

        The benefits or amounts that will be received by or allocated to employees, executives, other officers and directors of the Company under the amended and restated 2005 Plan are not determinable. However, if the proposed amended and restated 2005 Plan had been in effect during 2016 (in lieu of the 2005 Plan as actually in effect during 2016), the Named Executive Officers and the groups shown below would have received the same grants that they received during 2016 under the 2005 Plan, which were as follows:

Name
  Number
of Restricted Stock Units(1)
  Dollar
Value of Stock
Awards(2)
 

Officers Remaining with the Company

 

Patrick M. Byrne

      $  

Robert P. Hughes

    15,000   $ 216,150  

Saum Noursalehi

    20,000   $ 288,200  

Jonathan E. Johnson III

    15,000   $ 216,150  

Officers No Longer with the Company

 

Stormy D. Simon

    40,000   $ 576,400  

Mitchell L. Edwards

    29,586   $ 450,003  

Natalie A. Malaszenko

    15,000   $ 216,150  

Alec S. Wilkins

    15,000   $ 216,150  

All current executive officers (including all Named Executive Officers)

   
194,586
 
$

2,832,000
 

All current directors who are not executive officers(3)

    25,000   $ 364,250  

All employees, including all current officers who are not executive officers

    420,946   $ 6,084,430  

(1)
Grants shown are actual grants of restricted stock units made during 2016. The shares vest over a three-year period commencing on the date of grant in three equal annual increments.

(2)
Amount shown as Dollar Value for the Named Executive Officers is the grant date fair value of the actual awards made to them during 2016. Amounts shown as Dollar Value for the groups assume the same pricing used in the calculations for the Named Executive Officers.

(3)
Including Mr. Samuel A. Mitchell, who resigned from the Board on February 6, 2017.

14


Table of Contents

        On February 2, 2017 the Compensation Committee made annual equity grants to the Named Executive Officers and the groups shown below as follows:

Name
  Number
of Restricted Stock
Units(1)
  Dollar
Value of Stock
Awards(2)
 

Patrick M. Byrne

    20,000   $ 338,000  

Robert P. Hughes

    15,000   $ 253,500  

Saum Noursalehi

    32,500   $ 549,250  

Jonathan E. Johnson III

    10,000   $ 169,000  

All current executive officers (including the Named Executive Officers)

    162,500   $ 2,746,250  

All current directors who are not executive officers(3)

    25,000   $ 422,500  

All employees, including all current officers who are not executive officers

    225,500   $ 3,810,950  

(1)
Grants shown are actual grants of restricted stock units made on February 2, 2017. The shares vest over a three-year period commencing on the date of grant in three equal annual increments.

(2)
Amount shown as Dollar Value for the Named Executive Officers is the grant date fair value of the actual awards made to them on February 2, 2017. Amounts shown as Dollar Value for the groups assume the same pricing used in the calculations for the Named Executive Officers.

(3)
Including Mr. Samuel A. Mitchell, who resigned from the Board on February 6, 2017.

        The following table provides information as of December 31, 2016 with respect to shares of our common stock that may be issued under our existing equity compensation plans (consisting solely of our Amended and Restated 2005 Equity Incentive Plan).

Name
  Number of securities
to be issued upon
exercise of outstanding
options, warrants and
rights
  Weighted average
exercise price of
outstanding options,
warrants and rights(1)
  Number of securities
remaining available
for future issuance
 

Equity compensation plans approved by security holders

    716,163     3.78     2,083,414  

Equity compensation plans not approved by security holders

    0     N/A     N/A  

Total

    716,163     3.78     2,083,414  

(1)
At December 31, 2016 the weighted average exercise price excluding RSUs was $17.33.

        Please see "Summary of the Plan," below.

15


Table of Contents

        If our stockholders do not approve the amendment and restatement of the 2005 Plan, we will continue to make grants under the 2005 Plan as it is currently in effect. Our executive officers and non-employee directors have an interest in this proposal, as they may receive awards under the amended and restated 2005 Plan. However, whether the proposal is approved or not, our executive officers and non-employee directors may continue to receive awards under the 2005 Plan as currently in effect. Approval of the proposal will not increase the number of shares available under the 2005 Plan, and will not have any effect on the number of shares, if any, that may be subject to awards granted in the future to any of our officers or employees, but will impose limits on awards to non-employee directors.

        The Board of Directors unanimously recommends a vote "FOR" Proposal 3, the approval of the amendment and restatement of the 2005 Plan, and to approve the material terms of the amended and restated 2005 Plan and the performance goals thereunder for purposes of Section 162(m) of the Internal Revenue Code.

Summary of the Plan

        The material features of the amended and restated 2005 Plan are summarized below. This summary does not purport to be complete and is subject to, and qualified in its entirety by, the provisions of the amended and restated 2005 Plan. Capitalized terms used herein and not defined shall have the meanings set forth in the amended and restated 2005 Plan.

        Purpose.    The purposes of the amended and restated 2005 Plan are to attract and retain the best available personnel, to provide additional incentive to our employees, consultants and non-employee directors, and to promote the success of our business.

        Administration.    The amended and restated 2005 Plan may be administered by our Board of Directors or a committee, which our Board of Directors may appoint from among its members (the "Administrator"). To the extent awards are intended to constitute "performance-based compensation" under Section 162(m) of the Internal Revenue Code, the amended and restated 2005 Plan will be administered by a committee of two or more "outside directors" within the meaning of Section 162(m) of the Internal Revenue Code. Subject to the provisions of the amended and restated 2005 Plan, the Administrator has the authority to: (i) interpret the amended and restated 2005 Plan, apply its provisions and reconcile any inconsistency, correct any defect and supply any omission in the plan or an award agreement; (ii) prescribe, amend or rescind rules and regulations relating to the amended and restated 2005 Plan; (iii) select the persons to whom awards are to be granted; (iv) subject to individual fiscal year limits applicable to each type of award, determine the number of shares or equivalent units to be made subject to each award; (v) determine whether and to what extent awards are to be granted; (vi) determine the terms and conditions applicable to awards generally and of each individual award (including the provisions of the award agreement to be entered into between the Company and the participant); (vii) amend any outstanding award subject to applicable legal restrictions; (viii) authorize any person to execute, on our behalf, any instrument required to effect the grant of an award; (ix) approve forms of agreement for use under the amended and restated 2005 Plan; (x) allow participants to satisfy minimum withholding tax obligations by tendering cash or shares owned by the participant or electing to have the Company withhold from the shares or cash to be issued that number of shares or cash having a fair market value equal to the minimum amount required to be withheld; (xi) reduce the exercise price of an award to the then current fair market value if the fair market value of the common stock covered by the award has declined since the date the award was granted, provided our stockholders have approved such action; (xii) institute an award exchange program, provided that no exchange will cause the exercise price of an award to be reduced unless our stockholders have approved such action; (xiii) determine the fair market value of our common stock; and (xiv) subject to certain limitations, take any other actions and make all other determinations

16


Table of Contents

deemed necessary or advisable for the administration of the amended and restated 2005 Plan. All decisions, interpretations and other actions of the Administrator shall be final and binding on all holders of awards and on all persons deriving their rights therefrom.

        Shares Available.    The proposed amendment does not change the number of shares authorized for grants under the plan. Whether the amended and restated plan is approved or not, an aggregate of 1,978,307 shares will be available for grant under the amended and restated 2005 Plan, adjusted for any shares forfeited or subjected to any award made after February 15, 2017. The shares of common stock covered by the amended and restated 2005 Plan may be authorized but unissued shares, or reacquired shares. To the extent that an award terminates, expires, or lapses for any reason, or an award is settled in cash without delivery of shares to the participant (but subject to the restrictions described herein relating to SARs), any shares subject to the award may be used again for new grants under the amended and restated 2005 Plan. The full number of SARs granted that are to be settled in shares of common stock will count against the number of shares available for award under the amended and restated 2005 Plan, regardless of how many shares are actually issued upon settlement of the SARs. Any shares surrendered or withheld to satisfy the exercise price of an option or withheld to satisfy minimum tax withholding obligations will count against the number of shares available for award under the amended and restated 2005 Plan. No fractional shares may be issued under the amended and restated 2005 Plan.

        Eligibility.    The amended and restated 2005 Plan provides that awards may be granted to our employees, consultants and non-employee directors, and employees and consultants of our subsidiaries, as determined by the Administrator. Incentive stock options may be granted only to employees (including officers and employee directors).

        Limitation on Awards to Non-Employee Directors.    The amended and restated 2005 Plan imposes new limits on the awards that may be granted under the existing 2005 Plan during any fiscal year to any non-employee director, taken together with any cash fees paid by the Company to such non-employee director during such fiscal year for service as a non-employee director. The new limits will not apply to any consulting fees or other compensation we may pay or provide to any non-employee director for services in addition to the services normally performed by a non-employee director. The amended and restated 2005 Plan provides that awards to any non-employee director plus the cash fees payable to such director during such fiscal year for service as an non-employee director will not exceed $400,000 in total value (calculating the value of any such awards based on the grant date fair value of such awards for financial reporting purposes), plus up to an additional $200,000 for service on any special committee of the Board. The average total value of the routine cash and equity grants we have paid to our non-employee directors over the last eight years is approximately $184,000.

        Internal Revenue Code Section 162(m) Performance Goals.    We have designed the amended and restated 2005 Plan so that it permits us to issue awards that are intended to qualify as performance-based under Section 162(m) of the Internal Revenue Code. Thus, the Administrator may make performance goals applicable to a participant with respect to an award. At the Administrator's discretion, one or more of the following performance criteria may apply as the basis of a performance goal: cash position, earnings per share, expenses, gross margin, individual objectives, net income, operating cash flow, operating income, operating margin, return on assets, return on equity, return on sales, revenue, total stockholder return, and/or unit sales, all as determined in accordance with accounting principles generally accepted in the United States or on a non-GAAP basis. A performance goal may apply either to us or to one of our business units. The Administrator may use other performance criteria for awards that are not intended to qualify as performance-based under Section 162(m) of the Internal Revenue Code. With regard to a particular performance period, the Administrator will have the discretion to select the length of the performance period, the type of performance-based awards to be granted, and the goals that will be used to measure the performance for the period. In determining the actual size of an individual performance-based award for a

17


Table of Contents

performance period, the Administrator may reduce or eliminate (but not increase) the initial award. Generally, a participant will have to be employed by or providing services to us on the date the performance-based award is paid to be eligible for a performance-based award for any period.

        Terms and Conditions of Options.    Each option granted under the amended and restated 2005 Plan is to be evidenced by a written stock option agreement between the optionee and the Company and is to be subject to the following terms and conditions:

18


Table of Contents

        Terms and Conditions of Stock Appreciation Rights.    The Administrator, subject to the provisions of the amended and restated 2005 Plan (including the 162(m) share limit referred to above), shall have complete discretion to determine the terms and conditions of SARs granted under the amended and restated 2005 Plan. Each SAR grant shall be evidenced by an agreement that shall specify the exercise price, the term of the SAR, the conditions of exercise, and such other terms and conditions as the Administrator, in its sole discretion, shall determine, and will be subject to the following terms and conditions:

19


Table of Contents

        Restricted Stock and Restricted Stock Units.    Subject to the terms and conditions of the amended and restated 2005 Plan, restricted stock and restricted stock units may be granted to our employees, directors and consultants at any time and from time to time at the discretion of the Administrator. Restricted stock is an award of our common stock, and a restricted stock unit is an award of hypothetical shares of our common stock having a value equal to the fair market value of an identical number of shares of common stock. The Company will not receive any consideration for the grant of restricted stock awards or restricted stock unit awards. Restricted stock and restricted stock units may, but need not, provide that the award will be subject to forfeiture and may not be sold, assigned, transferred or otherwise disposed of for a period of time determined by the Administrator. The Administrator shall have complete discretion to determine (i) the number of shares subject to a restricted stock or restricted stock unit award granted to any participant and (ii) the conditions for grant or for vesting that must be satisfied, which may be based principally or solely on continued provision of services but may include a performance-based component. However, no participant shall be granted a restricted stock or restricted stock unit award covering more than 100,000 shares in any fiscal year, except that up to 250,000 shares may be granted in the participant's first fiscal year of service.

        Voting and Dividend Rights.    Unless otherwise stated in the restricted stock agreement, a holder of restricted stock will have the rights and privileges of a stockholder, including the right to vote. Dividends on restricted stock may be currently paid to the holder or held by us until the restrictions on the shares are released. A holder of restricted stock units will not be a stockholder until the shares are issued, and until such time, no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the underlying shares.

        Restricted Stock Award Agreement.    Each restricted stock and restricted stock unit grant shall be evidenced by an agreement that shall specify the purchase price (if any) and such other terms and conditions as the Administrator shall determine; provided, however, that if the restricted stock or restricted stock unit grant has a purchase price, the purchase price must be paid no more than ten (10) years following the date of grant.

        Performance Shares.    Subject to the terms and conditions of the amended and restated 2005 Plan, performance shares may be granted to our employees, directors and consultants at any time and from time to time as shall be determined at the discretion of the Administrator. The Administrator shall have complete discretion to determine (i) the number of shares of our common stock subject to a

20


Table of Contents

performance share award granted to any service provider and (ii) the conditions that must be satisfied for grant or for vesting, which may be based principally or solely on achievement of performance milestones but may include a service-based component. However, no participant shall be granted performance shares covering more than 100,000 shares in any fiscal year, except that the limit shall be 250,000 shares in the participant's first fiscal year of service.

        Performance Share Award Agreement.    Each performance share grant shall be evidenced by an agreement that shall specify such other terms and conditions as the Administrator, in its sole discretion, shall determine.

        Performance Units.    Performance units are similar to performance shares, except that they shall be settled in cash equivalent to the fair market value of the underlying shares of our common stock, determined as of the vesting date. The shares available for issuance under the amended and restated 2005 Plan shall not be diminished as a result of the settlement of a performance unit.

        Performance Unit Award Agreement.    Each performance unit grant shall be evidenced by an agreement that shall specify such terms and conditions as shall be determined at the discretion of the Administrator. However, no participant shall be granted a performance unit award having an initial value greater than $1,000,000 in any fiscal year, except that the limit shall be $2,500,000 in the participant's first fiscal year of service.

        Deferred Stock Units.    Deferred stock units shall consist of a restricted stock, restricted stock unit, performance share or performance unit award that the Administrator, in its sole discretion, permits to be paid out in installments or on a deferred basis, in accordance with rules and procedures established by the Administrator. Deferred stock units are subject to the individual annual limits that apply to each type of award.

        Non-Transferability of Awards.    Unless determined otherwise by the Administrator, an award granted under the amended and restated 2005 Plan may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the recipient, only by the recipient. If the Administrator makes an award granted under the amended and restated 2005 Plan transferable, such award shall contain such additional terms and conditions as the Administrator deems appropriate.

        Acceleration upon Death.    Unless an award agreement provides otherwise, in the event that a participant dies while a service provider, the award may be exercised within the time period set forth in the relevant agreement, but in no event later than the expiration date of the relevant award.

        Adjustment Upon Changes in Capitalization.    In the event that our capital stock is changed by reason of any stock split, reverse stock split, stock dividend, combination or reclassification of our common stock or any other increase or decrease in the number of issued shares of common stock effected without receipt of consideration by us, appropriate proportional adjustments shall be made in the number and class of shares of stock subject to the amended and restated 2005 Plan, the individual fiscal year limits applicable to restricted stock, restricted stock units, performance share awards, performance units, SARs and options, the number and class of shares of stock subject to any award outstanding under the amended and restated 2005 Plan, and the exercise price of any such outstanding option or SAR or other award. Any such adjustment shall be made by the Administrator or the Compensation Committee of our Board of Directors, whose determination shall be conclusive.

21


Table of Contents

        Change of Control.    In the event of a change of control, the successor entity (or its parent or subsidiary) may assume or substitute each outstanding award. If the successor entity does not assume the awards or substitute equivalent awards, or if the successor entity is not publicly traded, such awards shall become 100% vested. In such event, the Administrator may take one or more actions with respect to outstanding options and SARs, including but not limited to giving participants a limited period of time to exercise options and SARs, cashing out options and SARs based on the difference between the change of control value of our common stock and the exercise price, or making adjustments to options and SARs as the Administrator deems appropriate to reflect the change of control. Generally, a "change of control" means a person or group (subject to certain exceptions) becomes the beneficial owner of our securities representing 50% or more of the total voting power represented by our outstanding securities; we sell or dispose of substantially all of our assets; a change in a majority of our Board of Directors occurs without the approval of our then incumbent directors within a one-year period; or a merger or consolidation occurs other than a merger or consolidation resulting in our outstanding voting securities immediately before the merger or consolidation continuing to represent at least 50% of the total voting power of the surviving entity represented by our outstanding securities immediately after the merger or consolidation.

        Amendment, Suspensions and Termination of the amended and restated 2005 Plan.    Our Board of Directors may amend, suspend or terminate the amended and restated 2005 Plan at any time; provided, however, that stockholder approval is required for any amendment to the extent necessary to comply with Section 422 of the Internal Revenue Code, or any other applicable rule or statute or by the rules of any stock exchange or automated quotation system on which the Company's shares may then be listed or quoted.

Federal Income Tax Information

        Incentive Stock Options.    An optionee who is granted an incentive stock option will not recognize taxable income either at the time the option is granted or upon its exercise, although the exercise is an adjustment for alternative minimum tax purposes and may subject the optionee to the alternative minimum tax. Upon the sale or exchange of the shares more than two years after grant of the option and one year after exercise of the option, any gain or loss will be treated as long-term capital gain or loss. If these holding periods are not satisfied, the optionee will recognize ordinary income at the time of sale or exchange equal to the difference between the exercise price and the lower of (i) the fair market value of the shares at the date of the option exercise or (ii) the sale price of the shares. Any gain or loss recognized on such a premature disposition of the shares in excess of the amount treated as ordinary income will be characterized as long-term or short-term capital gain or loss, depending on how long the optionee held the shares after the date of exercise.

        Non-statutory Stock Options.    All other options that do not qualify as incentive stock options are referred to as non-statutory options. An optionee will not recognize any taxable income at the time a non-statutory option is granted. However, upon its exercise, the optionee will recognize ordinary income generally measured as the excess of the then fair market value of the shares purchased over the exercise price. Any taxable income recognized in connection with an option exercise by an optionee who is also an employee of the Company will be subject to tax withholding by the Company. Upon resale of such shares by the optionee, any difference between the sales price and the optionee's purchase price, to the extent not recognized as taxable income as described above, will be treated as long-term or short-term capital gain or loss, depending on how long the optionee held the shares after the date of exercise.

        Stock Appreciation Rights.    No taxable income is reportable when an SAR is granted to a participant. Upon exercise, the participant will recognize ordinary income in an amount equal to the fair market value of any shares of our common stock received and/or the amount of cash received. Any

22


Table of Contents

additional gain or loss recognized upon any later disposition of the shares of our common stock would be a capital gain or loss.

        Restricted Stock.    A participant will not have taxable income upon the grant of an award of restricted stock unless the participant otherwise elects to be taxed at the time of grant pursuant to Section 83(b) of the Internal Revenue Code. On the date an award of restricted stock becomes transferable or is no longer subject to a substantial risk of forfeiture, the participant will have taxable compensation equal to the difference between the fair market value of the shares on that date over the amount the participant paid for such shares, if any, unless the participant made an election under Section 83(b) of the Internal Revenue Code to be taxed at the time of grant. If the participant made an election under Section 83(b) of the Internal Revenue Code, the participant will have taxable compensation at the time of grant equal to the difference between the fair market value of the shares on the grant date over the amount the participant paid for such shares, if any.

        Restricted Stock Units, Performance Units and Performance Shares.    A participant will not have taxable income upon grant of an award of restricted stock units, performance units or performance shares. Instead, he or she will recognize ordinary income at the time of receipt of the shares or cash equal to the fair market value (on the date of receipt) of the shares or cash received minus any amount paid for the shares of our common stock.

        Tax Effect for the Company.    We generally will be entitled to a tax deduction in connection with an award under the amended and restated 2005 Plan in an amount equal to the ordinary income realized by a participant and at the time the participant recognizes such income. Special rules limit the deductibility of compensation paid to our "covered employees," which are our chief executive officer or our three highest paid officers (other than the chief executive officer or the chief financial officer). Under Section 162(m) of the Internal Revenue Code, the annual compensation paid to any of these covered employees will be deductible only to the extent that it does not exceed $1,000,000. It is possible that compensation attributable to awards under the amended and restated 2005 Plan, when combined with all other types of compensation received by a covered employee from us, may cause this limitation to be exceeded in any particular year. Certain kinds of compensation, including qualified "performance-based compensation," are disregarded for purposes of the deduction limitation. In accordance with U.S. Treasury Regulations issued under Section 162(m) of the Internal Revenue Code, compensation attributable to stock awards will generally qualify as performance-based compensation if (1) the award is granted by a compensation committee composed solely of two or more "outside directors," (2) the plan contains a per-employee limitation on the number of awards which may be granted during a specified period, (3) the plan is approved by the stockholders, and (4) under the terms of the award, the amount of compensation an employee could receive is based solely on an increase in the value of the stock after the date of the grant (which requires that the exercise price of an option or SAR is not less than the fair market value of the stock on the date of grant), and for awards other than options and SARs, established performance criteria that must be met before the award actually will vest or be paid. The amended and restated 2005 Plan is designed to meet the requirements of Section 162(m) of the Internal Revenue Code; however, awards granted under the amended and restated 2005 Plan will only be treated as qualified performance-based compensation under Section 162(m) of the Internal Revenue Code if the awards and the procedures associated with them comply with all other requirements of Section 162(m) of the Internal Revenue Code. We cannot assure you that compensation attributable to awards granted under the amended and restated 2005 Plan will be treated as qualified performance-based compensation under Section 162(m) of the Internal Revenue Code and thus be deductible to us.

        Requirements Regarding "Deferred Compensation."    Certain of the benefits under the amended and restated 2005 Plan may constitute "deferred compensation" within the meaning of Section 409A of the Internal Revenue Code, a provision governing "nonqualified deferred compensation plans." Failure to

23


Table of Contents

comply with the requirements of the provisions of Section 409A regarding participant elections and the timing of payment distributions could result in the affected participants being required to recognize ordinary income for federal tax purposes earlier than expected, and to be subject to substantial penalties.

        The foregoing is only a summary of the effect of federal income taxation upon us and upon the participant, does not purport to be complete, and does not discuss the tax consequences of the participant's death or the income tax laws of any municipality, state or foreign country in which a participant may reside. It also does not discuss the potential application of Section 280G of the Internal Revenue Code, which can apply to an "excess parachute payment." Further, different rules may apply if the participant is also an officer, director, or 10% stockholder of the Company.

Other Information

        Clawbacks.    Awards which are subject to recovery under any law, government regulation or stock exchange listing requirement will be subject to such deductions and clawback as may be required to be made pursuant to such law, government regulation or stock exchange listing requirement (or any policy adopted by the Company pursuant to any such law, government regulation or stock exchange listing requirement).

        New Plan Benefits    The proposed amendment does not provide for any new plan benefits, and does not not change the number of shares authorized for grants under the 2005 plan. Whether the amended and restated 2005 plan is approved or not, an aggregate of 1,978,307 shares will be available for grant under the amended and restated 2005 Plan (or under the existing 2005 Plan), adjusted for any shares forfeited or subjected to any award made after February 15, 2017. The grant of awards under the amended and restated 2005 Plan, including grants to our named executive officers and directors, is discretionary. As of the date of this proxy statement, there has been no determination with respect to future awards under the amended and restated 2005 Plan. Accordingly, the amount of any future discretionary awards is not determinable. Information about the grant of awards under our 2005 Plan during the fiscal year ended December 31, 2016 to (a) non-employee directors; (b) our Named Executive Officers; (c) all current executive officers as a group; and (d) all other officers and employees as a group is provided above. In addition, we have provided above similar information about the grants made to the same groups in February 2017.

        The Board of Directors unanimously recommends a vote "FOR" Proposal 3—Approval of an Amendment and Restatement of our 2005 Equity Incentive Plan.

PROPOSAL 4—ADVISORY VOTE ON THE COMPENSATION PAID BY THE COMPANY TO ITS NAMED EXECUTIVE OFFICERS ("SAY ON PAY VOTE")

        Pursuant to the Dodd-Frank Act, we are asking our stockholders to approve, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to Item 402 of Regulation S-K.

        Our executive compensation is discussed in further detail below under the caption "Executive Compensation—Compensation Discussion and Analysis," which, together with the sections following the Compensation Discussion and Analysis, includes information about the fiscal year 2016 compensation of our named executive officers, as well as a discussion of actions regarding executive compensation that were taken after December 31, 2016.

        We are asking our stockholders to indicate their support for the compensation of our named executive officers, as described in this proxy statement. This proposal, commonly known as a

24


Table of Contents

"say-on-pay" proposal, is not intended to address any specific item of compensation, but rather the overall compensation of our named executive officers and the philosophy, policies and practices described in this proxy statement. Accordingly, we ask our stockholders to vote "FOR" the following resolution at our annual meeting:

        The say-on-pay vote is advisory and, therefore, not binding on the Board or on the Company; however, the Compensation Committee will consider the outcome of the vote when considering future executive compensation arrangements.

        The Board of Directors unanimously recommends a vote "FOR" approval of Proposal 4—advisory approval of the compensation paid by the Company to our named executive officers.

PROPOSAL 5—ADVISORY VOTE ON THE FREQUENCY (EVERY ONE, TWO OR THREE YEARS) OF FUTURE SAY ON PAY VOTES

        Pursuant to the Dodd-Frank Act, we are also asking our stockholders to indicate, on an advisory basis, the frequency of future advisory votes on executive compensation. (In other words, how often a proposal similar to this year's Proposal No. 4 will be included in the matters to be voted on at the annual stockholders meeting.) The choices available under the say on pay rules are every one year, every two years, every three years, or to abstain. At the 2011 annual meeting, our stockholders indicated their preference for us to hold advisory votes on executive compensation once every three years, and the current frequency of our advisory votes on executive compensation is once every three years. The next scheduled advisory vote on executive compensation is scheduled to occur at the May 9, 2017 annual meeting of stockholders.

        Please mark your proxy card to indicate your preference on this Proposal or your abstention if you wish to abstain. If you fail to indicate your preference or abstention, your shares will be treated as though you chose to abstain on this Proposal.

        The frequency selected by the stockholders for conducting say on pay voting at the annual stockholders meetings will not be binding on the Board or on the Company, and stockholders are not voting to approve or disapprove the Board's recommendation. However, the frequency selected will be considered by the Board of Directors.

        The Board of Directors unanimously recommends that you select once every THREE years in Proposal 5—the advisory vote on the frequency of future advisory stockholder votes on executive compensation under the say on pay rules.


OTHER BUSINESS

        The Board knows of no other business for consideration at the meeting. If other matters are properly presented at the meeting, or at any adjournment or postponement of the meeting, Messrs. Byrne and Johnson will vote, or otherwise act, on your behalf in accordance with the Board's (or, in the absence of instructions from the Board, their) judgment on such matters.

25


Table of Contents


THE BOARD

        The Board of Directors currently consists of six members. One of the nominees for election (Ms. Abraham) is a current member of the Board; and the other nominee, Mr. Noursalehi, is our President, Retail. Mr. Samuel A. Mitchell, who had served as a member of the Board since 2010, resigned in February 2017. The remaining five directors are expected to continue to serve their terms as described below. Assuming the election of both nominees at the Annual Meeting, the Board will consist of seven members. Our directors serve staggered terms. This is accomplished as follows:

        Unless otherwise instructed, the proxy holders will vote the proxies received by them for each of the nominees. If any nominee is unable or declines to serve as a director at or prior to the time of the Annual Meeting, the proxies will be voted for a substitute nominee, if any, designated by the Nominating and Corporate Governance Committee of the Board of Directors to fill the vacancy. The proxy holders intend to vote all proxies received by them in such a manner as will ensure the election of the nominees. The terms of office of the persons elected as Class III directors will continue until the 2020 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified or until their earlier incapacity, resignation or removal. It is not expected that any nominee will be unable or will decline to serve as a director.

        The Board has determined that a majority of our Board consists of independent members and will continue to consist of independent directors after the Annual Meeting. The Board has determined that each of our current directors is independent within the meaning of the Nasdaq director independence standards except for Patrick M. Byrne, who serves as our Chief Executive Officer, and Jonathan E. Johnson III, who serves as Chairman of the Board and President, Medici. Medici Ventures, Inc. is a wholly owned subsidiary of the Company. In addition, Mr. Johnson has previously served in a number of other executive positions with the Company. Saum Noursalehi, who is a nominee for election at the Annual Meeting and currently serves as our President, Retail, is also not independent.

        In reaching its determinations regarding the independence of the members of the Board, the Board considered the fact that Allison H. Abraham has no relationship with the Company except as a director and stockholder. With respect to Joseph J. Tabacco, Jr., the Board considered the fact that Mr. Tabacco's adult daughter works as an attorney for a law firm that has represented the Company in the past, and determined that Mr. Tabacco met the independence requirements. With respect to Barclay F. Corbus, the Board considered the fact that Mr. Corbus formerly served as Co-CEO of WR Hambrecht + Co., and considered the services that WR Hambrecht + Co. has performed for the Company in the past and determined that Mr. Corbus met the independence requirements. With respect to Mr. Mitchell, who resigned from the Board in February 2017, the Board considered the fact that Mr. Mitchell is a managing director of Hamblin Watsa Investment Counsel and a member of the investment committee, which manages the investment portfolios of Fairfax Financial Holdings Limited, which during 2016 was directly or indirectly the beneficial owner of approximately 12.6% of the Company's outstanding common stock, and determined that Mr. Mitchell met the independence standards. With respect to Dr. Kalyanam, the Board considered the fact that Dr. Kalyanam served as a consultant to the Company prior to and after his appointment as a director, and was paid $120,000

26


Table of Contents

during 2015 by the Company for his consulting services, and determined that Dr. Kalyanam met the independence standards.

        The Board of Directors has an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee, each of which has adopted a written charter. Current copies of the committee charters are available on the Company's website at http://investors.overstock.com. All members of the committees are appointed by the Board of Directors, and each member is independent within the meaning of the Nasdaq director independence standards and SEC rules. The committees are described in more detail below.

        Audit Committee.    The Board has a standing Audit Committee. During 2016 the Audit Committee consisted of Allison H. Abraham, who serves as Chair, Barclay F. Corbus, Samuel A. Mitchell and Joseph J. Tabacco, Jr., each of whom is independent within the meaning of the Nasdaq director independence standards. The Board of Directors has determined that each of Ms. Abraham, Mr. Corbus, Mr. Mitchell and Mr. Tabacco is an "audit committee financial expert" as defined by the SEC. The experience of each such director that led the Board to the determination that such director is an "audit committee financial expert" is described below under "Information Regarding Director Nominees and Other Directors." The Audit Committee is responsible for reviewing and monitoring our financial statements and our internal control over financial reporting, and selecting, reviewing and monitoring our independent registered public accounting firm, evaluating the scope of the annual audit, reviewing audit results, and consulting with management and our independent registered public accounting firm prior to presentation of financial statements to stockholders. The Report of the Audit Committee is included beginning on page 52 of this proxy statement.

        Compensation Committee.    The Board also has a standing Compensation Committee. During 2016 the Compensation Committee consisted of Barclay F. Corbus, who serves as Chair, Allison H. Abraham, Samuel A. Mitchell and Joseph J. Tabacco, Jr., each of whom is a non-employee and independent as described above. The Compensation Committee is responsible for approving salaries, incentives and other forms of compensation for our executive officers and certain other employees and administering various incentive compensation and benefit plans. The Compensation Committee Report is included on page 41 of this proxy statement.

        Nominating and Corporate Governance Committee.    The Board also has a standing Nominating and Corporate Governance Committee. During 2016 the Nominating and Corporate Governance Committee consisted of Joseph J. Tabacco, Jr., who serves as Chair, Barclay F. Corbus, Allison H. Abraham, and Samuel A. Mitchell, each of whom is a non-employee and independent as described above. The Committee has authority to recommend Board nominees to the full Board, and also has authority over matters of corporate governance. Each member of the Board of Directors has historically participated in the consideration of director nominees.

        The Board held 13 meetings during 2016. The Audit Committee held seven meetings during 2016; the Compensation Committee held three meetings during 2016; and the Nominating and Corporate Governance Committee held one meeting during 2016. Each incumbent director other than Dr. Kalyanam attended at least 75% of the meetings of the Board and of the total number of meetings held by all committees of the board on which he or she served during 2016. The non-management members of the Board of Directors meet regularly in executive session without management present.

27


Table of Contents

        Patrick M. Byrne serves as our principal executive officer and as a member of the Board of Directors. Jonathan E. Johnson III, who is currently President, Medici and has previously served as our President and in other executive capacities with the Company, has served as Chairman of the Board since 2014. At the Annual Meeting, Mr. Johnson intends to step down as Chairman (but remain a member of the Board), and the Board intends to appoint Allison Abraham as Board Chair. We have not named a lead independent director. At December 31, 2016, the Board consisted of seven directors; five of whom were independent. Mr. Mitchell's resignation in February 2017 reduced the number of directors on the Board to six, four of whom are independent. We believe that our leadership structure is appropriate because the size of the Board and the composition of the Board permit and encourage each member to take an active role in all discussions, and each member does actively participate in all substantive discussions. We believe that our current structure is serving the Company well at this time. Although Dr. Byrne previously served as both Chairman and Chief Executive Officer, the Board separated the roles of Chairman and Chief Executive Officer in 2014 based on its perceptions of the Company's best interests at the time, and the Board's intention to appoint Ms. Abraham as Chair is also based on the Board's perceptions of the Company's best interests. We do not have any procedures for deciding when to separate or combine these positions.

        The Board has delegated responsibility for oversight of risk management relating to compensation matters to the Compensation Committee, and for financial and other risk management to the Audit Committee, although the full Board remains involved in risk management. The Committees and the Board receive periodic reports from management regarding various aspects of the Company's risk management program. The manner in which the Board and Committees administer the oversight of risk management has not had any effect on the Board's leadership structure.

        The Nominating and Corporate Governance Committee has developed the Company's Corporate Governance Principles ("Principles"), which have been adopted by the Board. The Principles set forth the Committee's belief that while there are no specific minimum qualifications the Committee believes must be met by a candidate to be recommended by the Committee, candidates for election to the Board should have the highest professional and personal ethics and values. Candidates should have broad relevant experience, and should be committed to enhancing long-term stockholder value. They should be able and willing to provide insight and practical advice, and they must actively represent the interests of the stockholders. The Committee believes that a variety of types and a balance of knowledge, experience and capabilities among the members of the Board are in the best interests of the stockholders. The Principles set forth the Committee's belief that diversity of viewpoint, professional experience and other individual qualities and attributes should be considered to the extent that they relate to the contribution a director is expected to make to the Board and the Company. The Committee periodically reviews the Principles, including the portion regarding diversity. The ability of a candidate to make independent analytical inquiries, the ability to understand the Company's business, and the willingness of a candidate to devote adequate attention and time to the duties of the Board, are all relevant to the qualifications of a candidate. The specific experience, qualifications, attributes or skills that led the Committee to the conclusion that each director should be a director in light of our business and structure are described under "Information Regarding Director Nominees and Other Directors," below.

28


Table of Contents

        The Nominating and Corporate Governance Committee believes that the current Board composition is serving the stockholders of the Company well, and that the addition of Mr. Noursalehi to the Board will help to integrate his deep knowledge of the Company's retail business into the Board's oversight function. In the future, the Committee may consider additional candidates identified through current members of the Board, professional search firms, stockholders or other persons. Candidates may be evaluated at regular or special meetings of the Board, and may be considered at any point during the year.

        Stockholders may propose director candidates for general consideration by the Nominating and Corporate Governance Committee by submitting in proper written form the individual's name, qualifications, and the other information required by the Bylaws as described below in "Other Information—Procedure for Nominating Directors for Election at an Annual Meeting or a Special Meeting" to the Secretary of the Company. The Nominating and Corporate Governance Committee will evaluate any candidates recommended by stockholders against the same criteria applicable to the evaluation of candidates proposed by directors or management.

        The Committee has not approved any nominee for inclusion on our proxy card for the 2017 Annual Meeting other than Allison H. Abraham who is a current member of the Board, and Saum Noursalehi, who is our President, Retail. We have not paid a fee to any third party or parties to identify or evaluate or assist in identifying or evaluating potential nominees. The Committee did not receive, by a date not later than the 120th calendar day before the date of the Company's proxy statement released to security holders in connection with the previous year's annual meeting, a recommended nominee from a security holder that beneficially owned more than 5% of the Company's voting common stock for at least one year as of the date the recommendation was made, or from a group of security holders that beneficially owned, in the aggregate, more than 5% of the Company's voting common stock, with each of the securities used to calculate that ownership held for at least one year as of the date the recommendation was made.

        The Board has adopted resolutions to provide a formal process by which stockholders may communicate with the Board. The process adopted by the Board permits stockholders to communicate with the Board either in writing, addressed to the Board at the Company's headquarters at 799 W. Coliseum Way, Midvale, Utah 84047, or by e-mail, sent to boardofdirectors@overstock.com. All communications from stockholders regarding matters appropriate for stockholder communications with the Board and delivered as described will be delivered to one or more Board members. The determination whether a communication involves a matter appropriate for stockholder communications with the Board is made by the Chair of the Board or our General Counsel. Stockholders who desire to utilize the procedures described under "Other Information—Procedure for Submitting Stockholder Proposals" or "—Procedure for Nominating Directors for Election at an Annual Meeting or a Special Meeting" should read those sections and the applicable portions of our bylaws and follow the procedures described.

        Our policy is that Board members should attend annual stockholders meetings if reasonably possible. All members of the Board attended the last annual stockholders meeting, which was held in May 2016.

29


Table of Contents

        We have adopted a code of business conduct and ethics that applies to all of our directors and employees. We will provide a copy of the code of ethics to any person without charge, upon request. Requests for a copy of the code of ethics may be made in writing addressed to: General Counsel, Overstock.com, Inc., 799 W. Coliseum Way, Midvale, Utah 84047.

        The Board has established a written policy and procedures for the review and approval or ratification of related party transactions. Under the Board's policy, any related party transaction that would be required to be disclosed pursuant to Item 404 of Regulation S-K is subject to the prior approval of the Audit Committee unless prior approval is not feasible, in which case the transaction is required to be considered at the Audit Committee's next meeting and, if the Audit Committee determines it to be appropriate, may be ratified at that meeting. In determining whether to approve or ratify a related party transaction, the Audit Committee takes into account, among other factors it deems appropriate, whether the transaction is on terms no less favorable to us than terms generally available from an unrelated person under the same or similar circumstances, and the extent of the related person's interest in the transaction. No member of the Audit Committee may participate in any approval or ratification of a related party transaction in which such member is a related person, other than to provide the Audit Committee with all material information regarding the transaction, including information regarding the extent of the member's interest in the transaction, except that the Audit Committee may allow one or more members to participate in any approval or ratification of a related party transaction or potential related party transaction in which such member(s) is or may be a related person if the Audit Committee determines that doing so is in the best interests of the Company and its stockholders and informs the Board of Directors of any such approval. If a related party transaction will be ongoing, the Audit Committee may establish guidelines or other parameters or conditions relating to our participation in the transaction. The Audit Committee may from time to time pre-approve types or categories of transactions by related persons.

        Set forth below is certain information regarding the nominees for election and all other directors of Overstock whose term of office continues after the 2017 Annual Meeting.


Class I Directors (Terms Expiring in 2018)

Name
  Age   Position with the Company   Director Since

Patrick M. Byrne

    53   Chief Executive Officer   October 1999

Barclay F. Corbus

    49   None   March 2007

Jonathan E. Johnson III

    50   President, Medici   May 2013

        Dr. Patrick M. Byrne has served as our Chief Executive Officer (principal executive officer), subject to medical leaves of absence in 2013 and 2016, and as a Director since October 1999, as Chairman of the Board from February 2001 through October 2005, and July 2006 through April 2014. From September 1997 to May 1999, Dr. Byrne served as President and Chief Executive Officer of Fechheimer Brothers, Inc., a manufacturer and distributor of uniforms. From 1995 until its sale in September 1999, Dr. Byrne was Chairman, President and Chief Executive Officer of Centricut, LLC, a manufacturer and distributor of industrial torch parts. From 1994 to the present, Dr. Byrne has served as a Manager of the Haverford Group, an investment company and an affiliate of Overstock. Dr. Byrne has a Bachelor of Arts degree in Chinese studies from Dartmouth College, a Master's Degree from Cambridge University as a Marshall Scholar, and a Ph.D. in philosophy from Stanford University. The specific experience, qualifications, attributes or skills that led the Board to conclude that Dr. Byrne

30


Table of Contents

should serve as a director in light of our business and structure were the following. Dr. Byrne has led the Company from revenues of approximately $1.8 million in 1999 to $1.8 billion for the year ended December 31, 2016. He has served as our Chief Executive Officer since 1999 (subject to medical leaves of absence in 2013 and 2016), and has also been directly in charge of marketing, merchandising and other senior executive management functions from time to time. In addition to being the Company's founder, largest stockholder and Chief Executive Officer, Dr. Byrne has led and continues to lead the development of the Company's evolving business model, and he is the Company's chief long-term strategic planner.

        Mr. Barclay F. Corbus has served as a Director of Overstock since March 2007. He is a member of the Audit Committee and the Nominating and Corporate Governance Committee, and is the Chairman of the Compensation Committee. Mr. Corbus has served as Senior Vice President of Clean Energy Fuels Corp., a provider of vehicular natural gas, with responsibility for strategic development, since September 2007. He served as Co-CEO of WR Hambrecht + Co., an investment banking firm, from July 2004 to September 2007, and prior to that date served in other executive positions with WR Hambrecht + Co. Prior to joining WR Hambrecht + Co in March 1999, Mr. Corbus was in the investment banking group at Donaldson, Lufkin and Jenrette. Mr. Corbus graduated from Dartmouth College with a Bachelor of Arts Degree in Government and has a Master's Degree of Business Administration in Finance from Columbia Business School. The specific experience, qualifications, attributes or skills that led the Board to conclude that Mr. Corbus should serve as a director in light of our business and structure were his substantial experience in finance, management, and strategic planning, as well as his experience analyzing and evaluating corporate business plans, capital structures and needs, and debt, equity and hybrid financing alternatives resulting from his work for Clean Energy Fuels Corp., WR Hambrecht + Co., and Donaldson, Lufkin and Jenrette.

        Mr. Jonathan E. Johnson III joined Overstock in September 2002 and has served as a Director since May 2013. Mr. Johnson currently serves as President, Medici. He has also served as Chairman of the Board of Directors since 2014, but intends to step down from that position at the Annual Meeting. He served as our President from July 2008 to February 2013, as our Acting Chief Executive Officer from February 2013 to April 2013, and as Executive Vice Chairman of the Board and Corporate Secretary from April 2013 to April 2014. Prior to his service as our President, Mr. Johnson served as our General Counsel and as our Vice President, Strategic Projects and Legal, and Senior Vice President, Corporate Affairs and Legal. Mr. Johnson holds a Bachelor's Degree in Japanese from Brigham Young University, studied for a year at Osaka University of Foreign Studies in Japan, and received his law degree from the J. Reuben Clark Law School at Brigham Young University. Mr. Johnson served on the Board of Governors of the Salt Lake Chamber of Commerce for many years. He serves on the executive committee of the Board of Trustees of the Utah Technology Council, the executive committee of the Board of Trustees of the Utah Foundation, the Board of Trustees of the University of Utah Hospital Foundation, the Board of Trustees of the Hale Center Theatre, and the Board of Directors of the National Museum of American Religion. The specific experience, qualifications, attributes or skills that led the Board to conclude that Mr. Johnson should serve as a director in light of our business and structure were his experience as our General Counsel, as our Vice President, Strategic Projects and Legal, as our Senior Vice President, Corporate Affairs, as our President, and as our Acting Chief Executive Officer.

31


Table of Contents


Class II Directors (Terms Expiring in 2019)

Name
  Age   Position with the Company   Director Since

Kirthi Kalyanam

    52   None   February 2015

Joseph J. Tabacco, Jr

    68   None   June 2007

        Dr. Kirthi Kalyanam has served as Director of Overstock since February 2015. He is currently the J.C. Penney Research Professor and Director of the Retail Management Institute at the Leavey School of Business at Santa Clara University. He has also served as Faculty Director of the Executive MBA program, a visiting Professor at the Graduate School of Business at Stanford University, a guest faculty in the Stanford Executive MMP program, and Senior Vice President and Chief Marketing Officer of SpinCircuit Inc., a provider of supply chain integration services to the electronics industry. He received his Ph.D. in business administration from the Krannert School of Management, Purdue University. His research and expertise are in retailing, Internet and multi-channel marketing, quantitative marketing and the intersection of these areas. Dr. Kalyanam performs consulting services for several companies, including Overstock. The specific experience, qualifications, attributes or skills that led the Board to conclude that Dr. Kalyanam should serve as a director in light of our business and structure were his extensive expertise in in retailing, Internet and multi-channel marketing and quantitative marketing.

        Mr. Joseph J. Tabacco, Jr. has served as a Director of Overstock since June 2007. He is a member of the Audit Committee and the Compensation Committee and is the Chairman of the Nominating and Corporate Governance Committee. For more than the last five years Mr. Tabacco has served as the managing partner of the San Francisco office of Berman DeValerio (formerly Berman DeValerio Pease Tabacco Burt & Pucillo). A 1974 honors graduate of George Washington University School of Law, Mr. Tabacco litigates antitrust, securities fraud, commercial high tech, and intellectual property matters. Since entering private practice in the early 1980s, Mr. Tabacco has served as trial or lead counsel in numerous antitrust and securities cases and has been involved in all aspects of state and federal litigation. Prior to 1981, Mr. Tabacco served as senior trial attorney for the U.S. Department of Justice, Antitrust Division, and in both the Central District of California and the Southern District of New York. Mr. Tabacco frequently lectures and authors articles on securities and antitrust law issues and is a member of the Advisory Board of the Institute for Consumer Antitrust Studies at Loyola University Chicago School of Law. Mr. Tabacco is also a former teaching fellow of the Attorney General's Advocacy Institute in Washington, D.C., and has served on the faculty of ALI-ABA on programs about U.S.-Canadian business litigation and trial of complex securities cases. The specific experience, qualifications, attributes or skills that led the Board to conclude that Mr. Tabacco should serve as a director in light of our business and structure were his extensive experience as a practicing attorney, litigating in the fields of securities fraud, corporate governance, general business litigation and antitrust litigation, including substantial litigation on behalf of investors, including public pension funds and other institutional investors as well as individual investors, in a wide variety of cases involving publicly traded companies, as well as his familiarity with state and federal competition laws and intellectual property rights.


Class III Directors (and Nominees for Election for Terms Expiring in 2020)

Name
  Age   Position with the Company   Director Since

Allison H. Abraham

    54   None   March 2002

Saum Noursalehi

    38   President, Retail   N/A

        Ms. Allison H. Abraham has served as a Director of Overstock since March 2002 and is currently the President and Founder of The Newton School, a private, non-profit elementary and middle school located in Sterling, Virginia. She is a member of the Compensation Committee and Nominating and Corporate Governance Committee and is the Chair of the Audit Committee. Ms. Abraham managed

32


Table of Contents

her own consulting business from October 2001 to November 2008, and has served as a director of privately-held Precision Imaging, Inc. since November 2002. Previously, Ms. Abraham served as President and as a director of LifeMinders, Inc. from May 2000 until October 2001. Prior to joining LifeMinders, Ms. Abraham served as Chief Operating Officer of iVillage Inc. from May 1998 to May 2000. From February 1997 to April 1998, Ms. Abraham was President, Chief Operating Officer and a Director of Shoppers Express. From 1992 to 1996, Ms. Abraham held several marketing and management positions at Ameritech Corporation. She was employed at American Express Travel Related Services in New York City from 1988 to 1992. Ms. Abraham holds a Bachelor of Arts Degree in Economics from Tufts University and a Master's Degree of Business Administration from the Darden School at the University of Virginia. The specific experience, qualifications, attributes or skills that led the Board to conclude that Ms. Abraham should serve as a director in light of our business and structure were Ms. Abraham's substantial marketing experience and experience running online marketing companies, including her marketing experience with American Express Travel Related Services, her marketing and management positions with Ameritech Corporation, her experience as Vice President of Sales and Marketing and subsequently as President, Chief Operating Officer and a director of Shoppers Express, her experience as Chief Operating Officer of iVillage Inc., and her experience as President and as a director of LifeMinders, Inc.

        Mr. Saum Noursalehi has served as our President since August 2016. He previously served as our chief revenue officer and as a senior vice president. Prior to his appointment as senior vice president in 2013, Mr. Noursalehi served as vice president of OLabs and held roles in website, mobile and search engine optimization. He was responsible for the creation of several core technologies for Overstock, including in-house search and recommendation engines, product sort algorithms, and a vendor application designed to optimize product content. He also spearheaded the implementation of automated email campaigns based on customer behavior. Additionally, he led a full redesign of both the desktop and mobile websites, and oversaw the development of Overstock's mobile apps, which have won five consecutive Mobile Web Awards for Best Retail App from the Web Marketing Association. Mr. Noursalehi joined Overstock in 2005 as a software engineer. Before joining Overstock, Noursalehi worked at the Utah Administrative Office of the Courts, Brooks Automation, and technology startup Infopia. Mr. Noursalehi received a Bachelor's Degree in Computer Science from the University of Utah, has been profiled in publications such as Wired, and was a recipient of the 2015 Utah Business Forty Under 40 award honoring Utah's top up-and-coming professionals. The specific experience, qualifications, attributes or skills that led the Board to conclude that Mr. Noursalehi should serve as a director in light of our business and structure were his combined deep expertise in our technology and marketing strategy.

33


Table of Contents


COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

        The members of the Compensation Committee during 2016 were Barclay F. Corbus (Chair), Allison H. Abraham, Joseph J. Tabacco, Jr. and Samuel A. Mitchell. During 2016:

EXECUTIVE COMPENSATION

COMPENSATION DISCUSSION AND ANALYSIS

Introduction

        The Compensation Committee administers our executive compensation program. The Compensation Committee, which consists entirely of independent directors, is responsible for reviewing and approving our compensation policies, for reviewing and approving all forms of compensation for our executive officers, including our named executive officers identified in the Summary Compensation Table below (the "Named Executive Officers"), for administering our incentive compensation programs, for approving and overseeing the administration of our employee benefits programs other than medical benefits programs, and for providing insight and guidance to management with respect to employee compensation and retention generally. Following is a discussion of the objectives and implementation of our executive compensation programs.

        The Compensation Committee operates under a charter adopted by the Board of Directors. The Compensation Committee periodically reviews the adequacy of its charter and recommends changes to the Board for approval as it considers appropriate. The Compensation Committee meets at scheduled times during the year and also acts from time to time by written consent. The Compensation Committee reports on its activities and makes recommendations at meetings of the Board. The Compensation Committee reviews comparative executive compensation information from other public companies, approves executive salaries, approves awards under incentive/bonus plans, and administers the Company's 2005 Equity Incentive Plan. Additionally, from time to time, the Compensation Committee reviews other human resource issues, including qualified and non-qualified benefits and management performance appraisals and succession planning. During 2016, our Chief Executive Officer (Dr. Byrne) (our "CEO"), our President, our Senior Vice President, Finance and Risk Management, our Senior Vice President, People and Customer Care, our Senior Vice President, Technology, and other executive officers made recommendations and participated in compensation discussions concerning executive officers. The Compensation Committee does not have the power to delegate any of its authority to any other person. Our CEO does not participate in any Compensation Committee deliberations regarding his compensation, but, as he has done for the last few years, informed the Committee prior to its deliberations that he would not accept any bonus payment and would not accept a salary of more than $100,000. Our compensation arrangements with one of our Named Executive Officers, Mitchell L. Edwards, who served as our Acting CEO during a portion of 2016, are described separately below.

34


Table of Contents

2014 Say on Pay Vote and 2011 Say on When Vote

        At the 2014 annual stockholders meeting our stockholders voted, on an advisory basis, to approve our executive compensation. The Compensation Committee was aware of the results of the advisory vote in 2016 when it made compensation decisions. In approving executives' 2016 compensation, while the Compensation Committee viewed the favorable vote as validation of our executive compensation, the Compensation Committee's awareness of the advisory vote did not affect the Committee's decisions regarding 2016 compensation. The Compensation Committee intends to consider the results of the 2017 say on pay vote in future compensation decisions.

        At the 2011 annual stockholders meeting the stockholders voted, on an advisory basis, to approve the Board's recommendation that future advisory votes regarding our executive compensation be held once every three years. We will hold another "say on pay" vote as well as another "say on when" vote at the upcoming annual meeting.

Compensation Objectives

        Our executive compensation programs seek to attract and retain highly competent executive management who will build long-term economic value for the Company. Our general compensation philosophy for our executives is that our executives' cash compensation should generally be at levels that are sufficient to retain the services of the executives, but that our executives' opportunities for more significant compensation should be tied closely to our performance.

        The objectives of our executive compensation plans and programs are to:

        Our executive compensation policy is designed to reward decisions and actions that have a positive effect on our financial performance and long-term stock value, and to balance short-term and long-term goals. Since 2008 our approach to equity awards has been to make an annual grant of restricted stock units ("RSUs") in an effort to create an equity awards system that will have long-term motivational effects tied directly to our stock price, subject to compliance with the vesting requirements. We believe that annual RSU grants, with multi-year vesting requirements, made over a number of years, should have the desired effect of providing appropriate incentives tied to the market price of the common stock over a long period of time, without encouraging short-term or inappropriate management decisions.

        In 2016 we concluded that the broad-based bonus pool approach we had used in prior years was not providing adequate incentives to key employees. Consequently, in 2016, in lieu of a Company-wide bonus pool plan, we offered specific bonus opportunities to selected employees for achieving specific objectives. Please see "—Executive Compensation Action Taken After Year-End" below, for more information about our recent changes to our approach to our bonus plan.

        The Compensation Committee and management, including the Named Executive Officers, believe that the best way to provide significant incentive compensation to the Named Executive Officers is through equity awards under our equity incentive plan, as described below.

        The accounting and tax treatment of particular forms of compensation generally do not affect the Compensation Committee's compensation decisions.

35


Table of Contents

Employment Agreements

        None of our Named Executive Officers has an employment or severance agreement. However, during 2016 we implemented an executive retention plan in which some of our Named Executive Officers were participants. The plan terminated December 31, 2016 and we have not replaced it. See "Severance and Change of Control Arrangements."

Retirement Benefits

        We do not offer any pension plan or other retirement benefits except a 401(k) plan and a nonqualified deferred compensation plan for senior management. At December 31, 2016 none of our Named Executive Officers participated in the nonqualified deferred compensation plan.

Role of Compensation Consultants

        During 2016 neither the Compensation Committee nor the Company engaged or received advice from any compensation consultant.

Elements of Compensation

        The elements of total compensation for which our Named Executive Officers other than our CEO were eligible during 2016 were as follows:

        Each of these elements is discussed below.

        Our CEO.    In 2016, our CEO Dr. Byrne informed the Compensation Committee that he would not accept any award under our 2005 Equity Incentive Plan, any bonus, or any other compensation other than his salary of $100,000 annually. Prior to 2011, our CEO had never accepted a salary. He has never participated in any of our bonus plans or otherwise received any bonus.

        Our Acting CEO.    On April 11, 2016, our CEO Dr. Byrne began an indefinite personal leave of absence for medical reasons, and our then Senior Vice President and General Counsel, Mitchell L. Edwards, was named acting Chief Executive Officer. Mr. Edwards' 2016 compensation arrangement permitted him to select a combination of cash and a single grant of restricted stock units with a combined total value of $1 million. On or about May 10, 2016 Mr. Edwards selected and the Compensation Committee granted to him a restricted stock unit ("RSU") grant of 29,586 RSUs having a grant date value of approximately $457,000. The RSUs were to vest on March 1, 2017, provided Mr. Edwards remained employed by the Company until such date, but subject to accelerated vesting upon any of the following: (1) a change in control of the Company, (2) the Company's termination of Mr. Edwards' employment without cause, or (3) a decrease in Mr. Edwards' responsibilities from those of Acting Chief Executive Officer, provided that if any such decrease in responsibilities occurred during 2016, the acceleration of vesting was to occur on January 1, 2017, subject to Mr. Edwards remaining employed by the Company until such date. On July 27, 2016, Dr. Byrne resumed his position as Chief Executive Officer and Mr. Edwards resigned from his positions as acting Chief Executive Officer and

36


Table of Contents

General Counsel. On or about September 7, 2016 the Compensation Committee accelerated the vesting of all of Mr. Edwards' RSUs. Mr. Edwards subsequently left the Company.

        Base Salary.    The base salaries of the Named Executive Officers are reviewed by the Compensation Committee annually, and are generally set annually. Salaries for the Named Executive Officers (other than Mr. Edwards) for 2016 were set in March 2016. Salaries for 2016 were maintained at the 2015 rates for each of Dr. Byrne, Mr. Johnson, Mr. Hughes, Mr. Edwards, Mr. Wilkins and Ms. Simon. Salaries for 2016 were increased for Mr. Noursalehi from $300,000 to $325,000 because of his increased duties as Senior Vice President, Product Development; and for Ms. Malaszenko from $260,000 to $300,000 because of her increased duties as Senior Vice President, Marketing. Mr. Noursalehi's salary was increased again in August 2016 to $400,000 as a result of his increased duties as President, Retail; and Mr. Johnson's salary was increased in August 2016 from $300,000 to $350,000 because of his additional duties as President, Medici.

        2016 Bonus Payments.    In 2016 we concluded that the broad-based bonus pool approach we had used in prior years, which was intended to provide an annual cash incentive to a large group of employees including the Named Executive Officers, was not providing adequate incentives to key employees. Consequently, in 2016, in lieu of a Company-wide bonus pool plan, we offered specific bonus opportunities to selected employees for achieving specific objectives. As described in the Summary Compensation Table, only two of our Named Executive Officers received any bonus payment ($50,000 each) relating to 2016.

        2005 Equity Incentive Plan.    We use the grant of awards under our 2005 Equity Incentive Plan to provide long-term incentive compensation opportunities to our key employees, including the Named Executive Officers. The plan was most recently reapproved by the stockholders in 2012 and is being submitted to the stockholders for re-approval at the upcoming annual meeting (see proposal 3). It provides for the grant of awards, including qualified and non-qualified stock options to purchase shares of our common stock. Options granted under the plan were granted at a per share exercise price which was not less than 100% of the fair market value of the underlying shares on the date that the option was granted. Accordingly, options granted under the plan had no intrinsic value unless the market price of our common stock increased after the date of grant. We have not granted any options since 2008.

        The plan also provides for the grant of restricted stock awards and other types of awards, although prior to 2008 we had not made any such awards. The plan is designed to provide incentive compensation that aligns management's financial interests with those of our stockholders and encourages management ownership of our common stock. Beginning in 2008, the Compensation Committee has approved annual grants of RSUs under the plan. The Compensation Committee determines the number of RSUs to be granted to key employees, including Named Executive Officers, based on a recommendation of management including the active participation during 2016 of the CEO and the President, by determining the aggregate amount the Committee considers appropriate for the entire group and allocating the awards on the basis of management's recommendation and the Compensation Committee's subjective views of the relative ability of key employees or groups of key employees to make positive contributions to the Company. Prior to 2014, we generally made equity grants to key employees, including Named Executive Officers, annually at a regularly scheduled Compensation Committee meeting typically held in late January or early February of each year. In 2016, we made these equity grants in late March. We have not otherwise adopted any specific policy regarding the amount or timing of any stock-based compensation for employees under the plan, although the aggregate amount of the equity grants to employees in recent years has generally been a number of shares approximately equal to 1-2% of the number of shares outstanding, and the annual grant typically occurs during the first half of the year. We have never backdated or repriced options or any other equity award. The aggregate grant date fair value of equity-based awards is set forth in the Summary Compensation Table. Information concerning the number of options and RSUs held by each

37


Table of Contents

Named Executive Officer as of December 31, 2016 is set forth in the Outstanding Equity Awards at Fiscal Year-End Table. With the changes we made in 2013-2016 to our bonus plans and the additional changes we made in 2017, the annual RSU grants to our Named Executive Officers have been the most significant incentive compensation arrangement we utilize.

        401(k) Plan.    We maintain a 401(k) plan, in which Named Executive Officers may participate. During 2016 we made 100% matching contributions on the first 6% of eligible compensation deferred by employees. Such matching amounts vested immediately. We did not make any profit sharing contributions in 2016. The amounts of the matching contributions to our Named Executive Officers are included in the "All Other Compensation" column of the Summary Compensation Table. Participation in the 401(k) plan is available to employees on a non-discriminatory basis.

        Health and Welfare Benefits.    We provide health, life and disability insurance and other employee benefits programs to our employees, including our Named Executive Officers. We also provide supplemental disability insurance for our senior management team members, including the Named Executive Officers. Except for the supplemental disability insurance, our employee benefits plans are provided on a non-discriminatory basis. The amounts of the supplemental disability insurance premium payments we make for the benefit of our Named Executive Officers are included in the "All Other Compensation" column of the Summary Compensation Table.

        Nonqualified Deferred Compensation Plan.    We have a nonqualified deferred compensation plan for senior management (the "Deferred Compensation Plan"). The Deferred Compensation Plan, which is described in more detail below, allows participants to defer receipt of compensation otherwise payable to them under our existing compensation plans, and also permits us to make discretionary contributions to participants' accounts. We have never made any discretionary contributions to participants' accounts. At December 31, 2016 none of our Named Executive Officers had any funds in the Deferred Compensation Plan.

        Why We Pay these Elements of Compensation; How We Determine the Amounts; and Interrelationships of these Elements.    The main elements of compensation potentially available to our Named Executive Officers (other than our Chief Executive Officer) for 2016 were base salary and RSU grants, with the possibility of bonus payments for achieving specific objectives. The three elements operate independently of one another. Each year the Compensation Committee considers the value of each component and the total value of the compensation package being provided to each of the Named Executive Officers, as well as the history of each officer's compensation package. The base salaries we paid the Named Executive Officers during 2016 were paid in order to retain the services of those executives. In setting 2016 salaries for the Named Executive Officers, the Compensation Committee reviewed the history of each Named Executive Officer's salary, bonuses and equity-based grants in prior years. The Compensation Committee did not benchmark the 2016 salaries, but reviewed 2014 cash compensation data we obtained from public filings with the SEC for each of HealthEquity, Inc., Headwaters, Inc., Myriad Genetics, Inc., Nu Skin Enterprises, Inc., Sportsman's Warehouse Holdings, Inc. and USANA Health Sciences, Inc., each of which is a publicly-traded company based in Utah with 2014 revenues ranging from approximately $88 million to $2.6 billion (the "Utah Companies"). We selected these six companies because we believe that public companies based in Utah are likely competition for our executives. The Compensation Committee also reviewed 2014 cash compensation data from each of IAC/InterActiveCorp, Netflix, Inc., 1-800-FLOWERS.COM, Inc., Wayfair, Inc. and Amazon.com, Inc., each of which is or was a publicly held company with a significant retail e-commerce business (the "Internet Retail Companies"). We selected these five companies because they are publicly-traded Internet retailers that are either competitors or have revenues comparable to ours.

        Except as described above under "Our Acting CEO," the Compensation Committee granted RSUs to our Named Executive Officers and other key employees in March 2016 to provide long-term

38


Table of Contents

incentive compensation tied directly to the price of the Company's common stock. The grants were intended to have a retention effect, as they vest in equal annual increments over a three-year period. They were also intended to provide reasonable incentives tied to the price of the Company's common stock, which the Compensation Committee believes to be in the best interests of stockholders generally.

        The two Named Executive Officers who received a bonus payment in 2016 each received a $50,000 bonus for their multi-year efforts in the successful settlement in early 2016 of our long-running litigation against a number of broker-dealers.

        We provide the 401(k) plan and the health and welfare benefits to help make our overall compensation packages more attractive to all our employees, including our Named Executive Officers.

        Risks of Our Compensation Policies and Practices.    We periodically analyze and evaluate risks arising from our compensation policies and practices, and have concluded that our compensation policies and practices are not reasonably likely to have a material adverse effect on us.

Nonqualified Deferred Compensation Plan

        We have a nonqualified deferred compensation plan for senior management (the "Deferred Compensation Plan"). The Deferred Compensation Plan allows participants to defer receipt of compensation otherwise payable to them under our existing compensation plans, and also permits us to make discretionary contributions to participants' accounts. Participants are permitted to select from a limited number of investment alternatives available under the Plan. Under the terms of the Deferred Compensation Plan, eligible members of senior management, including the Named Executive Officers, may defer receipt of their compensation, including up to 50% of their salaries and up to 90% of their bonuses. We may, though we have no obligation to, make discretionary contributions on behalf of a participant in the Deferred Compensation Plan, in such form and amount as we deem appropriate. To date, we have not made any contributions to the Deferred Compensation Plan on behalf of any Named Executive Officer. We have never paid any above-market or preferential earnings on any compensation deferred under the Deferred Compensation Plan. At December 31, 2016 none of our Named Executive Officers had any funds in the Deferred Compensation Plan.

Executive Compensation Action Taken After Year-End

        The Compensation Committee did not take any action relating to 2016 compensation of any Named Executive Officer after December 31, 2016.

        On February 2, 2017 the Compensation Committee set 2017 salaries and approved restricted stock unit grants under the Company's 2005 Equity Incentive Plan to officers of the Company, including the Named Executive Officers as summarized below. The Compensation Committee also approved a bonus plan for 2017, but officers at the senior vice president level and above are not eligible to participate in the bonus plan and consequently none of the Named Executive Officers is expected to be eligible to participate in the plan. Although the Named Executive Officers are not expected to be eligible for any bonuses relating to 2017, it is possible that one or more of them may receive a bonus for completion of

39


Table of Contents

a specific objective. However, we have no plans for any such bonus opportunities for any of our Named Executive Officers at the date of this proxy statement.

Name and Title
  2017 Salary   Restricted Stock Unit Grant(1)  

Patrick M. Byrne

  $ 100,000     20,000  

Robert P. Hughes

  $ 300,000     15,000  

Saum Noursalehi

  $ 400,000     32,500  

Jonathan E. Johnson III

  $ 350,000     10,000  

(1)
Restricted stock unit grants are made pursuant to the Company's 2005 Equity Incentive Plan and will vest in three equal annual increments. Figures shown are the number of units/shares.

Timing of Equity Awards

        We did not grant any stock options to any of our Named Executive Officers during 2016. We do not have any program, plan or practice to time option grants, RSU awards or any other equity awards to our Named Executive Officers or to any other employee in coordination with the release of material non-public information. The Company's Board of Directors and Board committees, including the Compensation Committee, normally schedule their regular meetings at least a year in advance. Meetings of the Compensation Committee are generally held in connection with the regularly scheduled Board meetings. The meetings are scheduled in an effort to meet a number of different timing objectives, including the review of financial results and the review of press releases and filings containing financial results. The Compensation Committee may approve equity awards shortly before or after the public release of financial results or other material information, because the Compensation Committee holds its meetings in connection with the Board meetings, not because of a program, plan or practice to time option grants or other equity awards. We also do not set the grant date of any equity awards to new executives in coordination with the release of material non-public information, and we have not timed, and do not plan to time, the release of material non-public information for the purpose of affecting the value of executive compensation.

Severance and Change of Control Arrangements

        None of our executive officers has any contractual right to any severance or change of control payments under any employment or severance agreement although we do sometimes make severance payments. During 2016 we implemented a short term executive retention plan; however, the retention plan expired December 31, 2016. The executive retention plan is discussed below under "Potential Payments Upon Termination or Change of Control." Our executive officers hold RSUs, issued under our 2005 Equity Incentive Plan, and the vesting of such awards may be accelerated, under certain circumstances, upon or in connection with a change of control of the Company or upon the termination of the employment of the holder within a period of time after a change of control has occurred. The 2005 Equity Incentive Plan provides that if a merger or change of control (as defined in the plan) occurs, outstanding awards will be assumed by the successor or an equivalent award will be substituted, or the award will vest and the participant will have the right to exercise the award. The 2005 Equity Incentive Plan also provides that the Board has the power to modify any outstanding awards at any time, by accelerating vesting or otherwise. In addition, as described above, our Deferred Compensation Plan allows participants to defer receipt of compensation otherwise payable to them under our existing compensation plans, and permits us to make discretionary contributions to participants' accounts. Participants are fully vested in all amounts deferred and any earnings or losses on those deferrals at all times. Upon termination of service due to retirement, disability or death, a participant becomes fully vested in any additional amounts, including any discretionary contributions we make, credited to his or her account. To date, we have not made any contributions to the Deferred Compensation Plan on

40


Table of Contents

behalf of any Named Executive Officer, and at December 31, 2016 none of our Named Executive Officers had any funds in the Deferred Compensation Plan.

Security Ownership Requirements

        We do not have any policy requiring our Named Executive Officers or directors to own any specified amount of our common stock. Our CEO beneficially owns approximately 26.6% of our common stock.

Hedging Policy

        We have a policy prohibiting directors, officers and other employees and members of their immediate families from engaging in short sales of our stock or otherwise engaging in any transaction intended to hedge against or profit from any decrease in the market value of our securities.


COMPENSATION COMMITTEE REPORT

        The Compensation Committee has reviewed the Compensation Discussion and Analysis and discussed it with management. Based on its review and discussions with management, the Compensation Committee recommended to our Board of Directors that the Compensation Discussion and Analysis be included in the Company's 2017 proxy statement and in the Company's Annual Report on Form 10-K for the year ended December 31, 2016.

Barclay F. Corbus (Chair)
Allison H. Abraham
Joseph J. Tabacco, Jr.

41


Table of Contents

Compensation Paid to Executive Officers

        The following table sets forth information for the three years ended December 31, 2016 concerning the compensation for services in all capacities to the Company and its subsidiaries of (i) both persons who served as our principal executive officer at any time during 2016, (ii) our principal financial officer, (iii) our other three most highly compensated executive officers who were serving as such at December 31, 2016, and (iv) two additional individuals for whom disclosure would have been provided but for the fact that the individuals were not serving as executive officers at December 31, 2016. We refer to these individuals throughout this proxy statement as the "Named Executive Officers."


SUMMARY COMPENSATION TABLE

Name and Principal Position
  Year   Salary
($)
  Bonus   Stock
Awards(1)
($)
  Non-equity
Incentive Plan
Compensation(2)
($)
  All Other
Compensation(3)
($)
  Total
($)
 

Officers Remaining with the Company

 

Patrick M. Byrne

   
2016
 
$

81,539
   
   
   
 
$

4,662
 
$

86,201
 

Chief Executive Officer and

    2015   $ 100,385       $ 247,400           $ 347,785  

Director (principal

    2014   $ 100,000       $ 257,310           $ 357,310  

executive officer)

                                           

Robert P. Hughes

   
2016
 
$

300,003
   
 
$

216,150
   
 
$

23,608
 
$

539,761
 

Senior Vice President, Finance

    2015   $ 301,155       $ 185,550   $ 5,377   $ 21,286   $ 513,368  

and Risk Management

    2014   $ 300,000       $ 214,425   $ 4,402   $ 21,136   $ 539,963  

(principal financial officer)

                                         

Saum Noursalehi

   
2016
 
$

351,058
   
 
$

288,200
   
 
$

19,105
 
$

658,363
 

President, Retail(4)

    2015   $ 301,155       $ 185,550   $ 5,377   $ 20,347 (4) $ 512,429  

Jonathan E. Johnson III

   
2016
 
$

321,539
 
$

50,000
 
$

216,150
   
 
$

26,461
 
$

614,150
 

President, Medici and

    2015   $ 307,308       $ 185,550   $ 5,487   $ 27,148   $ 525,493  

Chairman of the Board(5)

    2014   $ 350,000       $ 257,310   $ 5,136   $ 27,323   $ 639,769  

Officers No Longer with the Company

 

Stormy D. Simon

   
2016
 
$

226,154
 
$

50,000
 
$

576,400
   
 
$

692,000
 
$

1,544,554
 

Former President and

    2015   $ 395,385       $ 494,800   $ 7,059   $ 19,976   $ 917,220  

Director(6)

    2014   $ 350,000       $ 257,310   $ 5,136   $ 21,008   $ 633,454  

Mitchell L. Edwards

   
2016
 
$

518,885
   
 
$

450,003
   
 
$

48,079
 
$

1,016,967
 

Former Acting Chief

                                           

Executive Officer and

                                           

General Counsel(7)

                                           

Natalie A. Malaszenko

   
2016
 
$

306,001
   
 
$

216,150
   
 
$

298,279
 
$

820,429
 

Former Senior Vice President

                                           

Marketing(8)

                                           

Alec S. Wilkins

   
2016
 
$

283,847
   
 
$

216,150
   
 
$

323,592
 
$

823,589
 

Former Senior Vice President

                                           

and Chief Architect(9)

                                           

(1)
The Stock Awards represent the grant date fair value, without reduction for estimated forfeitures, of stock awards granted to Named Executive Officers, determined in accordance with FASB ASC Topic 718.

(2)
Non-equity Incentive Plan Compensation was paid under our 2015 and 2014 annual bonus pool plans. Non-equity Incentive Plan Compensation shown for 2014 was paid in February 2015 and relates to 2014. Non-equity Incentive Plan Compensation shown for 2015 was paid in February 2016 and relates to 2015. No non-equity Incentive Plan Compensation was paid for 2016.

42


Table of Contents

(3)
Amounts shown include Company-provided 401(k) matching contributions. We made 100% matching contributions on the first 6% of eligible compensation deferred by employees in 2014, 2015 and 2016. All Other Compensation for 2016 includes the Company's 401(k) contributions during 2016 in the following amounts: Dr. Byrne: $4,662; Mr. Hughes: $15,900; Mr. Noursalehi: $15,900; Mr. Johnson: $15,900; Ms. Simon: $15,420; Mr. Edwards: $15,900; Ms. Malaszenko: $15,900; and Mr. Wilkins: $12,046. All Other Compensation for 2016 also includes the premiums paid by the Company for supplemental disability insurance during 2016 in the following amounts: Dr. Byrne: $0; Mr. Hughes: $5,386; Mr. Noursalehi: $2,719; Mr. Johnson: $4,398; Ms. Simon: $2,718; Mr. Edwards: $0; Ms. Malaszenko: $444 and Mr. Wilkins: $2,823.

(4)
Mr. Noursalehi was not a Named Executive Officer during 2014; consequently information for 2014 is not included.

(5)
Mr. Johnson was not a Named Executive Officer in 2015; however, we disclosed his 2015 compensation information in the 2015 Director Compensation Table and have included it in this summary compensation table. The $50,000 bonus Mr. Johnson received was a success bonus for leading litigation which the Company settled in January 2016. The bonus was paid on February 2, 2016. All Other Compensation for Mr. Johnson also includes $3,950 we paid for his membership in the Young Presidents Association, $541 we paid for his Utah State Bar dues and $430 we paid for his California bar dues.

(6)
Ms. Simon resigned as President on July 25, 2016 and resigned as a member of the Board on September 30, 2016. All Other Compensation for Ms. Simon includes a severance payment of $325,000, the value of the acceleration of 19,759 restricted stock units on September 30, 2016 of $302,708, and a paid time off payout of $46,154. The grant date value of the accelerated restricted stock units was also previously reported in the years in which the grants were made. The $50,000 bonus Ms. Simon received was a success bonus for helping with litigation which the Company settled in January 2016. The bonus was paid on February 2, 2016.

(7)
Mr. Edwards resigned from his positions as acting Chief Executive Officer and General Counsel on July 27, 2016. All Other Compensation for Mr. Edwards includes a paid time off payout of $30,510. Mr. Edwards was not a Named Executive Officer prior to 2016; consequently information for 2014 and 2015 is not included.

(8)
Ms. Malaszenko resigned effective January 3, 2017. All Other Compensation for Ms. Malaszenko includes a severance payment of $254,264 paid on January 13, 2017 and a paid time off payout of $22,367. Ms. Malaszenko was not a Named Executive Officer prior to 2016; consequently information for 2014 and 2015 is not included.

(9)
Mr. Wilkins resigned from his positions as Senior Vice President and Chief Architect on August 1, 2016 and resigned from the Company effective December 10, 2016. All Other Compensation for Mr. Wilkins includes a severance payment of $273,974 and a paid time off payout of $34,618. Mr. Wilkins was not a Named Executive Officer prior to 2016; consequently information for 2014 and 2015 is not included.

        The material factors necessary to understand the summary compensation table above and the grants of plan-based awards table below are described above in the Compensation Discussion and Analysis and in the footnotes to the Summary Compensation Table.

Grants of Plan-Based Awards

        The following table sets forth information concerning grants of awards pursuant to plans made to the Named Executive Officers during the year ended December 31, 2016.

43


Table of Contents


GRANTS OF PLAN-BASED AWARDS

Name
  Grant Date For
Equity-Based
Awards
  All Other Stock
Awards: Number
of Shares of
Stock or Units(1)
  Grant Date Fair
Value of Stock
Awards(2)
 

Officers Remaining with the Company

 

Patrick M. Byrne(3)

          $  

Robert P. Hughes

    March 24, 2016     15,000   $ 216,150  

Saum Noursalehi

    March 24, 2016     20,000   $ 288,200  

Jonathan E. Johnson III

    March 24, 2016     15,000   $ 216,150  

Officers No Longer with the Company

 

Stormy D. Simon

    March 24, 2016     40,000   $ 576,400  

Mitchell L. Edwards

    May 10, 2016     29,586   $ 450,003  

Natalie A. Malaszenko

    March 24, 2016     15,000   $ 216,150  

Alec S. Wilkins

    March 24, 2016     15,000   $ 216,150  

(1)
Amounts reported relate to RSU grants under our 2005 Equity Incentive Plan, all of which were made on March 24, 2016 except the award to Mr. Edwards, which was made on May 10, 2016. See "—Elements of Compensation—Our Acting CEO," and "—2005 Equity Incentive Plan," above.

(2)
The amounts represent the grant date fair value, without reduction for estimated forfeitures, of stock awards granted to Named Executive Officers, determined in accordance with FASB ASC Topic 718. The fair market value of the shares on the grant date was $14.41 per share for all Named Executive Officers except Mr. Edwards. The fair market value of the shares on the grant date for Mr. Edwards was $15.21 per share. All the awards except the award to Mr. Edwards vest in three equal annual increments on the first three anniversaries of the applicable grant date. The award to Mr. Edwards vested completely on September 9, 2016.

(3)
Dr. Byrne declined any equity award relating to 2016.

Outstanding Equity Awards at Fiscal Year-End

        The following table sets forth information concerning outstanding equity awards held by each Named Executive Officer as of December 31, 2016.

44


Table of Contents

OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END(1)

 
  Option Awards(2)   Stock Awards(3)    
 
Name
  Number of
Securities
Underlying
Unexercised
Options (#)
Exercisable
  Number of
Securities
Underlying
Unexercised
Options (#)
Unexercisable
  Option
Exercise
Price ($)
  Option
Expiration
Date
  Number
of Shares
or Units
That
Have Not
Vested (#)
  Market
Value of
Shares or
Units That
Have Not
Vested ($)(4)
  Award
Grant
Date
 

Officers Remaining with the Company

 

Patrick M. Byrne

                    3,000   $ 52,500     01/28/14  

                    6,667   $ 116,672     04/07/15  

Robert P. Hughes

                    2,500   $ 43,750     01/28/14  

                    5,000   $ 87,500     04/07/15  

                    15,000   $ 262,500     03/24/16  

Saum Noursalehi

                    2,500   $ 43,750     01/28/14  

                    5,000   $ 87,500     04/07/15  

                    20,000   $ 350,000     03/24/16  

Jonathan E. Johnson III

    40,000         17.08     02/07/17             02/07/07  

                    3,000   $ 52,500     01/28/14  

                    5,000   $ 87,500     04/07/15  

                    15,000   $ 262,500     03/24/16  

Officers No Longer with the Company

 

Stormy D. Simon(5)

                               

Mitchell L. Edwards(6)

                               

Natalie A. Malaszenko(7)

                    1,950   $ 34,125     04/07/15  

                    15,000   $ 262,500     03/24/16  

Alec S. Wilkins(8)

                               

(1)
Awards shown in this table consist of option and RSU grants under the Company's 2005 Equity Incentive Plan.

(2)
Grant dates are shown under "Award Grant Date." Options vested over the first four years of the option term at a rate of 28% at the end of the first year and 2% per month thereafter.

(3)
Grant dates are shown under "Award Grant Date." RSUs awarded during 2016, 2015 and 2014 vest over a three-year period commencing on the date of grant in three equal annual increments.

(4)
Market values have been computed by multiplying the closing market price of the stock on December 30, 2016, which was $17.50, by the number of shares or units.

(5)
Ms. Simon resigned prior to December 31, 2016. All outstanding awards expired upon her resignation.

(6)
Mr. Edwards resigned prior to December 31, 2016. All outstanding awards, if any, expired upon his resignation.

(7)
Ms. Malaszenko resigned effective January 3, 2017. All outstanding awards expired upon her resignation.

(8)
Mr. Wilkins resigned prior to December 31, 2016. All outstanding awards, if any, expired upon his resignation.

45


Table of Contents

Option Exercises and Stock Vested in 2016

        The following table sets forth information concerning stock awards that vested during the last fiscal year with respect to the Named Executive Officers.


OPTION EXERCISES AND STOCK VESTED

 
  Option Awards   Stock Awards  
Name
  Number of Shares
Acquired on
Exercise
  Value Awarded on
exercise
  Number of
Shares Acquired
on Vestings (#)
  Value
Realized on
Vestings(1)($)
 

Officers Remaining with the Company

 

Patrick M. Byrne

            11,583   $ 136,956  

Robert P. Hughes

            7,250   $ 87,085  

Saum Noursalehi

            7,250   $ 87,085  

Jonathan E. Johnson III

            10,750   $ 125,045  

Officers No Longer with the Company

 

Stormy D. Simon

    40,000   $ 75,022     33,925   $ 479,182  

Mitchell L. Edwards

            29,586   $ 457,104  

Natalie A. Malaszenko

            975   $ 14,430  

Alec S. Wilkins

            3,816   $ 51,488  

(1)
Amount is the number of shares of stock acquired upon vesting multiplied by the market price (closing price) of the Company's common stock on the vesting date (or the preceding trading day if the vesting date was not a trading day).

Nonqualified Deferred Compensation Plan

        The following table sets forth information concerning our nonqualified deferred compensation plan for senior management. The Deferred Compensation Plan allows participants to defer receipt of compensation otherwise payable to them under our existing compensation plans, and also permits us to make discretionary contributions to participants' accounts. We may, though we have no obligation to, make discretionary contributions on behalf of a participant in the Deferred Compensation Plan, in such form and amount as we deem appropriate. To date, we have not made any contributions to the Deferred Compensation Plan on behalf of any Named Executive Officer. Participants are permitted to select from a limited number of investment alternatives, which are identified below. The investment alternatives were selected by the Company. A participant may change his or her selection of investment funds no more than six times each year. Eligible members of senior management, including the Named Executive Officers, may defer receipt of their compensation, including up to 50% of their salaries and up to 90% of their bonuses. Subject to plan restrictions and subject to prior distribution as a result of retirement, separation from service for other reasons, disability or death, and subject to other restrictions, each participant designates the timing of his or her distributions and whether payment is to be made in a lump sum or in equal annual installments over a period of up to five years. Subject to various restrictions, a participant may periodically change the timing of his or her distributions. At December 31, 2016 none of our Named Executive Officers participated in the Deferred Compensation Plan.

46


Table of Contents


NONQUALIFIED DEFERRED COMPENSATION

Name
  Executive
Contributions
in 2016 ($)(1)
  Registrant
Contributions
in 2016 ($)
  Aggregate
Earnings in
2016 ($)(1)
  Aggregate
Withdrawals/
Distributions
($)
  Aggregate
Balance at
December 31,
2016 ($)(1)
 

Officers Remaining with the Company

 

Patrick M. Byrne

  $   $   $   $   $  

Robert P. Hughes

  $   $   $   $   $  

Saum Noursalehi

  $   $   $   $   $  

Jonathan E. Johnson III

  $   $   $   $   $  

Officers No Longer with the Company

 

Stormy D. Simon

  $   $   $ (1,159 ) $ 17,502   $  

Mitchell L. Edwards

  $   $   $   $   $  

Natalie A. Malaszenko

  $   $   $   $   $  

Alec S. Wilkins

  $   $   $   $   $  

(1)
All of the 2016 contributions, and none of the 2016 earnings, are reported in the 2016 Summary Compensation Table as compensation. Of the amounts reported in the aggregate balance at December 31, 2016, all of the prior years' contributions were reported in the Summary Compensation Table as compensation for previous years. The 2016 aggregate earnings were calculated based on the actual return on the following funds or securities: American Century Equity Income Fund (actual return: 19.49%); Columbia Acorn International (actual return: –2.28%); Fidelity Balanced Fund (actual return: 7.01%); Fidelity Contra Fund (actual return: 3.37%); Fidelity Low Price Stock Fund (actual return: 8.79%); Fidelity Prime Money Market Institutional Fund (actual return: 0.52%); First American Government Obligations (actual return: 0.01%); Oppenheimer Developing Markets Fund (actual return: 0.74%); PIMCO Total Return Fund (actual return: 2.60%); Vanguard 500 Index Fund (actual return: 11.82%); and Overstock.com, Inc. Common Stock (actual return: 58.20%).


COMPENSATION OF DIRECTORS

        During 2016 we paid our non-employee directors annual cash fees at the rate of $60,000 annually, with payments on a quarterly basis, as we have done every year since 2008, except for 2012, when the independent directors volunteered to decrease their cash fees for the year to $50,000. In 2017 we will increase the non-employee directors' annual cash fees to $75,000 annually, paid quarterly. We also grant RSU awards to our non-employee directors annually, generally at the first Board meeting after the director first joins the Board, and then periodically thereafter. In 2016 we granted RSUs to our non-employee directors as follows:

Name
  Grant Date   Number of
Restricted Stock
Units(1)
  Closing Price
of Common
Stock on Date
 

Allison H. Abraham

    May 10, 2016     5,000   $ 15.21  

Barclay F. Corbus

    March 24, 2016     5,000   $ 14.41  

Kirthi Kalyanam

    March 24, 2016     5,000   $ 14.41  

Samuel A. Mitchell(2)

    March 24, 2016     5,000   $ 14.41  

Joseph J. Tabacco, Jr. 

    March 24, 2016     5,000   $ 14.41  

(1)
The RSUs vest over a three-year period in three equal annual increments on the first, second, and third anniversaries of the grant date.

(2)
Mr. Mitchell resigned from the Board on February 6, 2017 and forfeited all outstanding RSUs.

47


Table of Contents

        None of our directors or director nominee has any agreement or arrangement with any third party that relates to compensation or other payment in connection with that person's candidacy or service as a director of the Company. The Board's determination of the compensation that non-employee directors receive has two components. The first is the amount of time and effort the directors are required to devote to the Company's business. In making this evaluation, the Board takes into account that four of the five independent non-employee members of the Board during 2016 were also members of the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, and considers the time and effort the independent directors devote to their Board and committee responsibilities. The second component is the Board's perception of the approximate value of the grant of the RSUs, based on the recent and historical market values of the underlying common stock, and considering the restricted nature of the grants. The Board attempts to establish the annual grant at a level that, together with the quarterly cash compensation paid to the non-employee directors, provides fair compensation to the non-employee directors for their services to the Company. On an annual basis, the Company's Chairman and Chief Executive Officer have historically made recommendations regarding the RSU grants, and the Board members have discussed the proposals. None of the Board, any committee of the Board or the Company has retained any consultant or other advisor to make recommendations or otherwise be involved in decisions regarding the compensation of the non-employee directors.

        We have a Non-Employee Directors Nonqualified Deferred Compensation Plan, which allows directors to defer receipt of compensation otherwise payable to them under our existing compensation plans. The terms of the Non-Employee Directors Nonqualified Deferred Compensation Plan are substantially the same as those of our Nonqualified Deferred Compensation Plan for senior management. To date, none of our directors has elected to participate in the Non-Employee Directors Nonqualified Deferred Compensation Plan.

        The following table sets forth the compensation paid to or accrued by the Company with respect to each non-employee member of the Board of Directors during the year ended December 31, 2016. We also reimburse our directors for out-of-pocket expenses incurred in connection with attending Board and committee meetings.


DIRECTOR COMPENSATION TABLE

Name
  Fees Earned or
Paid in Cash
($)
  Stock
Awards(1)
($)
  Option
Awards(2)
($)
  All Other
Compensation
($)
  Total
($)
 

Allison H. Abraham

  $ 60,000   $ 76,050           $ 136,050  

Barclay F. Corbus

  $ 60,000   $ 72,050           $ 132,050  

Kirthi Kalyanam

  $ 60,000   $ 72,050           $ 132,050  

Samuel A. Mitchell(3)

  $ 60,000   $ 72,050           $ 132,050  

Joseph J. Tabacco, Jr.(4)

  $ 110,000   $ 72,050           $ 182,050  

(1)
The Stock Awards represent the grant date fair value, without reduction for estimated forfeitures, of restricted stock awards granted to non-employee members of our Board of Directors, determined in accordance with FASB ASC Topic 718. Each non-employee director received a single grant of 5,000 RSUs. All of the grants were made on March 24, 2016 except for the grant to Ms. Abraham, which was made on May 10, 2016. At December 31, 2016, the number of RSUs held by each non-employee director was as follows: Ms. Abraham: 8,501; Mr. Corbus: 8,501; Dr. Kalyanam: 7,334; Mr. Mitchell: 8,501; and Mr. Tabacco: 8,501.

(2)
No stock option awards were granted to non-employee members of our Board of Directors during 2016. At December 31, 2016, the number of options held by each non-employee director was as

48


Table of Contents

(3)
Mr. Mitchell resigned from the Board on February 6, 2017 and forfeited all outstanding RSUs.

(4)
In addition to $60,000 in director's fees, Mr. Tabacco was paid $50,000 for serving as chair of a special committee of the Board.


POTENTIAL PAYMENTS UPON TERMINATION OR CHANGE OF CONTROL

Termination—2016 Executive Retention Plan

        On July 27, 2016, the Board approved a short-term executive retention plan (the "Retention Plan") covering all of the Company's Senior Vice Presidents and Mr. Noursalehi. The Retention Plan provided for severance benefits for participants who were involuntarily terminated without "cause" during the term of the Retention Plan, which expired December 31, 2016. We did not make any payments pursuant to the Retention Plan and we have not adopted any replacement plan for the expired Retention Plan. Severance payments we actually paid to Named Executive Officers are shown in the Summary Compensation Table and in the second table below. For our other Named Executive Officers who were participants in the Retention Plan, the amount shown is the amount the Named Executive Officer could have received upon a qualifying termination occurring immediately prior to the expiration of the Retention Plan on December 31, 2016.

        Upon a qualifying termination under the Retention Plan, each participant was eligible to receive a lump sum payment equal to the participant's annual base salary and to vest in any portion of the participant's then unvested restricted stock unit awards scheduled to vest in the twelve months following the participant's termination date. Participants were to be required to execute a release in favor of the Company in exchange for receiving any Retention Plan benefits.

Acceleration upon change of control

        No Named Executive Officer is entitled to any payment or accelerated benefit in connection with a change of control of the Company, or a change in his or her responsibilities following a change of control, except for potential accelerated vesting of stock options and RSUs granted under our 2005 Equity Incentive Plan. The 2005 Equity Incentive Plan has complex definitions of "change of control" and resigning for "good reason." Generally speaking, a change of control occurs if (i) we sell or liquidate all or substantially all of our assets; (ii) with certain exceptions, someone, including a group, acquires beneficial ownership of 50% or more of our stock; (iii) a change in the composition of our Board occurs within a one-year period, resulting in less than a majority of our directors being persons approved by existing directors; or (iv) any merger or consolidation of the Company occurs with any other corporation, other than one resulting in the voting securities of the Company prior to the merger or consolidation continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least 50% of the total voting power of the Company or such surviving entity or its parent after such merger or consolidation.

        The 2005 Equity Incentive Plan is a "double trigger" plan, meaning that unvested stock options and unvested RSUs automatically vest immediately only if (i) there is a change of control and (ii) if stock options and RSUs are assumed or substituted with stock options or RSUs of the surviving company, the participant is terminated or resigns for good reason within 18 months after the change of control. Generally speaking, a resignation is "for good reason" if it results from: (i) the resigning participant having materially reduced duties, title, authority or responsibilities; (ii) the resigning participant having his or her base salary reduced; (iii) the resigning participant having his or her primary work location moved to a facility or a location outside of a 35-mile radius from our present facility or location, or (iv) any act or set of facts or circumstances which would, under applicable case

49


Table of Contents

law or statute, constitute a constructive termination of the participant. If the successor entity refuses to assume or substitute for outstanding equity awards, or if the successor entity does not have outstanding common equity securities required to be registered under Section 12 of the Securities Exchange Act of 1934, as amended, the participant will fully vest in the award. For purposes of the 2005 Equity Incentive Plan, an award will be considered assumed if, following the change of control, the award confers the right to purchase or receive, for each share subject to the award immediately prior to the change of control, the consideration (whether stock, cash, or other securities or property) received in the change of control by holders of common stock for each share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the change of control is not solely common stock of the successor entity or its parent, the administrator of the 2005 Equity Incentive Plan may, with the consent of the successor entity, provide for the consideration to be received, for each share and each unit/right to acquire a share subject to the award, to be solely common stock of the successor entity or its parent equal in fair market value to the per share consideration received by holders of common stock in the change of control. The 2005 Equity Incentive Plan includes provisions intended to prevent violations of Section 409A of the Internal Revenue Code. It also provides that the Board has the power to modify any outstanding awards at any time, by accelerating vesting or otherwise.

No acceleration of equity awards upon retirement, death, disability.

        Neither options nor RSUs accelerate upon retirement, death or disability.

        The following table shows the estimated potential incremental value of stock options and RSUs that would have vested for our Named Executive Officers as of December 31, 2016 under the acceleration scenarios described above. The accelerated RSU award value is calculated by multiplying the number of accelerated units by the closing price of the underlying shares on December 31, 2016 ($17.50).

Name
  Change in
Control Only
  Change in Control
with No
Replacement Equity
  Change in Control
plus Qualifying
Termination
  Total-With
Acceleration
($)
 

Officers Remaining with the Company

 

Patrick M. Byrne

      $ 169,172   $ 169,172   $ 169,172  

Robert P. Hughes

      $ 393,750   $ 393,750   $ 393,750  

Saum Noursalehi

      $ 481,250   $ 481,250   $ 481,250  

Jonathan E. Johnson III

      $ 419,300   $ 419,300   $ 419,300  

Officers No Longer with the Company

 

Stormy D. Simon

                 

Mitchell L. Edwards

                 

Natalie A. Malaszenko

      $ 296,625   $ 296,625   $ 296,625  

Alec S. Wilkins

                 

        The following table shows the estimated potential aggregate amounts our Named Executive Officers could have realized from stock options, RSUs and Deferred Compensation Plan account distributions if their employment had terminated as of the last business day of fiscal 2016, both including and excluding amounts from accelerated vesting of stock options and RSUs as detailed in the table above. It also shows amounts the Named Executive Officer actually received or could have received upon a qualifying termination occurring immediately prior to the expiration of the Retention Plan on December 31, 2016. The "Total-No Acceleration" column assumes none of the acceleration scenarios covered above has occurred. The "Total-With Acceleration" column assumes acceleration of all unvested stock options and RSUs under one or more of the scenarios covered above. The "Total-With Acceleration and Qualifying Termination under Retention Plan" shows the aggregate amounts

50


Table of Contents

assuming acceleration of all unvested stock options and RSUs under one or more of the scenarios covered above and also a qualifying termination occurring immediately prior to the expiration of the Retention Plan on December 31, 2016.

Name
  Termination
Covered By
Retention
Plan(1)
  Aggregate
Value of
Vested Equity
Awards
($)
  Deferred
Compensation
Plan Account
Balances(2)
($)
  Total-No
Acceleration
($)
  Aggregate
Value of
Unvested
Equity
Awards
($)
  Total-With
Acceleration
($)
  Total-With
Acceleration
and
Qualifying
Termination
under
Retention
Plan(3)
 

Officers Remaining with the Company

 

Patrick M. Byrne

                  $ 169,172   $ 169,172   $ 169,172  

Robert P. Hughes

  $ 475,000               $ 393,750   $ 393,750   $ 693,750  

Saum Noursalehi

  $ 604,155               $ 481,250   $ 481,250   $ 881,250  

Jonathan E. Johnson III

      $ 16,800       $ 16,800   $ 402,500   $ 419,300   $ 419,300  

Officers No Longer with the Company

 

Stormy D. Simon

                             

Mitchell L. Edwards

                             

Natalie A. Malaszenko

    254,264               $ 296,625   $ 296,625      

Alec S. Wilkins

    273,974                          

(1)
None of Dr. Byrne, Mr. Johnson, Ms. Simon or Mr. Edwards was a participant in the Retention Plan. Amounts shown for Mr. Hughes and Mr. Noursalehi are their respective 2016 annual base salaries plus the portion of their respective unvested restricted stock unit awards scheduled to vest in the twelve months following December 31, 2016. The amounts shown for Mr. Wilkins and Ms. Malaszenko are the actual aggregate severance payments we paid them.

(2)
To date we have not made any contributions to the Deferred Compensation Plan on behalf of any Named Executive Officer.

(3)
Totals for Mr. Hughes and Mr. Noursalehi consist of the aggregate value of their unvested equity awards at December 31, 2016 plus the amount of their annual salaries as of Dcember 31, 2016.

Deferred compensation plan

        As described above, we have a Deferred Compensation Plan, which allows participants to defer receipt of compensation otherwise payable to them under our existing compensation plans, and also permits us to make discretionary contributions to participants' accounts. Participants are fully vested in all amounts deferred and any earnings or losses on those deferrals at all times. Upon termination of service due to retirement, disability or death, a participant becomes fully vested in any additional amounts, including any discretionary contributions we make, credited to his or her account. To date, we have not made any contributions to the Deferred Compensation Plan on behalf of any Named Executive Officer.

51


Table of Contents


EQUITY COMPENSATION PLAN INFORMATION

        The following table provides information as of December 31, 2016 with respect to shares of our common stock that may be issued under our existing equity compensation plans.

Name
  Number of securities
to be issued upon
exercise of outstanding
options, warrants and
rights
  Weighted average
exercise price of
outstanding options,
warrants and rights(1)
  Number of securities
remaining available
for future issuance
 

Equity compensation plans approved by security holders

    716,163     3.78     2,083,414  

Equity compensation plans not approved by security holders

    0     N/A     N/A  

Total

    716,163     3.78     2,083,414  

(1)
At December 31, 2016 the weighted average exercise price excluding RSUs was $17.33.


REPORT OF THE AUDIT COMMITTEE

        Notwithstanding anything to the contrary set forth in any of the Company's previous or future filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, that might incorporate this Proxy Statement, the following report shall not be deemed to be incorporated by reference into any such filings.

        The following report concerns the Audit Committee's activities regarding oversight of the Company's financial reporting and auditing process.

        The Audit Committee consists solely of independent directors, as defined by Nasdaq rules, and operates under a written charter adopted by the Board of Directors. The composition of the Audit Committee, the attributes of its members and the responsibilities of the Audit Committee, as reflected in its charter, are intended to be in accordance with applicable requirements for corporate audit committees. The Audit Committee reviews and assesses the adequacy of its charter on an annual basis.

        As described more fully in its charter, the purpose of the Audit Committee is to provide general oversight of the Company's financial reporting, internal control and audit functions. Management is responsible for the preparation, presentation and integrity of the Company's financial statements, accounting and financial reporting principles, and internal controls and procedures designed to ensure compliance with accounting standards, applicable laws and regulations. The Company's independent registered public accounting firm is responsible for performing an independent audit of the consolidated financial statements and the effectiveness of the Company's internal control over financial reporting in accordance with standards established by the Public Company Accounting Oversight Board.

        The Audit Committee serves a board-level oversight role, in which it provides advice, counsel and direction to management and the independent registered public accounting firm on the basis of the information it receives, discussions with management and the independent registered public accounting firm and the experience of the Audit Committee's members in business, financial and accounting matters.

        Among other matters, the Audit Committee monitors and approves the activities and performance of the Company's independent registered public accounting firm, including the audit scope, external audit fees, auditor independence matters and the extent to which the independent registered public accounting firm may be retained to perform non-audit services. The Audit Committee has authority and responsibility for the appointment, compensation, retention and oversight of the independent registered public accounting firm. The Audit Committee also reviews the results of the external audit

52


Table of Contents

work with regard to the adequacy and appropriateness of the Company's financial, accounting and internal controls.

        The Audit Committee has reviewed and discussed with management and the independent registered public accounting firm (i) the consolidated financial statements as of December 31, 2016 and 2015 and for each of the years in the three-year period ended December 31, 2016, (ii) management's assessment of the effectiveness of the Company's internal control over financial reporting as of December 31, 2016, and (iii) the independent registered public accounting firm's audit of the effectiveness of the Company's internal control over financial reporting as of December 31, 2016. Management has represented to the Audit Committee that the Company's consolidated financial statements were prepared in accordance with generally accepted accounting principles. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed in PCAOB Accounting Standards No. 1301. The Audit Committee has received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm's communications with the Audit Committee concerning independence, and has discussed with the independent registered public accounting firm the independent registered public accounting firm's independence.

        Based on the review and discussions referred to above with management and the independent registered public accounting firm, the Audit Committee recommended to the Board of Directors that the audited financial statements be included in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 for filing with the Commission.

Members of the Audit Committee
Allison H. Abraham (Chair)
Barclay F. Corbus
Joseph J. Tabacco, Jr.

53


Table of Contents


SHARE OWNERSHIP OF MANAGEMENT, DIRECTORS, NOMINEES AND 5% STOCKHOLDERS

        The following table sets forth information regarding the beneficial ownership of our common stock as of February 10, 2017 (except as otherwise noted below) by the following individuals or groups:

        The table is based upon information supplied by officers, directors, nominees and principal stockholders and Schedules 13D and 13G filed with the SEC. Except as otherwise indicated below or in the referenced filings, and subject to applicable community property laws, to our knowledge the persons named in the table have sole voting and investment power with respect to all shares of common stock held by them. Applicable percentages are based on 24,895,038 shares of common stock outstanding as of February 10, 2017, except as otherwise indicated below, and as adjusted as required by rules promulgated by the SEC. None of the numbers of shares or percentages shown include the total of 695,898 outstanding shares of our Blockchain Voting Series A Preferred Stock and our Voting Series B Preferred Stock (collectively, the "Preferred Stock"). Each share of Preferred Stock is entitled to one vote on each matter to be submitted to the stockholders at the Annual Meeting. Amounts based on Schedule 13G filings are as of December 31, 2016 unless otherwise noted.

 
  Shares
Beneficially Owned
 
Beneficial Owner (Name and Address)
  Number   Percent  

5% Stockholders

             

High Plains Investments LLC

    5,452,127 (1)   21.9 %

700 Bitner Road

             

Park City, UT 84098

             

The Dorothy M. Byrne 2014 GRAT No. 3, the Dorothy M. Byrne Article III Trust 3 and the Dorothy M. Byrne Revocable Trust

    1,577,983 (2)   6.3 %

16 King Road

             

P.O. Box 85

             

Etna, NH 03750

             

Directors, Nominees and Named Executive Officers

             

Patrick M. Byrne

    6,612,122 (3)   26.6 %

Allison H. Abraham

    53,266 (4)   *  

Barclay F. Corbus

    50,537 (5)   *  

Joseph J. Tabacco, Jr. 

    64,099 (6)   *  

Jonathan E. Johnson III

    86,174 (7)   *  

Kirthi Kalyanam. 

    4,449 (8)   *  

Robert P. Hughes

    46,119 (9)   *  

Saum Noursalehi

    23,688 (10)   *  

Officers No Longer with the Company

             

Stormy D. Simon

    160,783 (11)      

Mitchell L. Edwards

    21,204 (12)   *  

Natalie A. Malaszenko

    0 (13)   *  

Alec S. Wilkins

    4,445 (14)   *  

Directors and Executive Officers as a Group (19 persons)

   
7,189,991

(15)
 
28.9

%

*
Less than 1% of the outstanding shares of common stock.

54


Table of Contents

(1)
Patrick M. Byrne, our Chief Executive Officer, holds 100% of the voting interest in and controls High Plains Investments LLC. Voting and dispositive power are shared. High Plains Investments LLC has pledged 1,168,185 of such shares to a commercial bank in connection with the establishment of a line of credit to High Plains Investments LLC. Reference is hereby made to the Schedule 13D/A filed by Dr. Byrne and other reporting persons on February 23, 2017 for information about the number of shares and the nature of the beneficial ownership held by each such person.

(2)
The Dorothy M. Byrne 2014 GRAT No. 3 has shared voting and dispositive power over 172,576 shares. The Dorothy M. Byrne Article III Trust 3 has shared voting and dispositive power over 352,675 shares. The Dorothy M. Byrne Revocable Trust has shared voting and dispositive power over 1,052,732 shares. Robert Snyder, 16 King Road, P.O. Box 85, Etna, NH 03750 has shared voting power and dispositive power over 1,577,983 shares. Daniel Mosley, Cravath, Swaine & Moore LLP, 825 Eighth Avenue, New York, NY 10019 has shared voting power and dispositive power over 1,577,983 shares.

(3)
Patrick M. Byrne's shares include 5,452,127 shares held by High Plains Investments LLC, as to which voting and investment power are shared and 119,972 shares held by The Patrick Byrne Foundation, Inc., as to which voting and investment power are shared. Dr. Byrne's shares include 3,333 shares issuable under stock-based awards. Dr. Byrne pledged 232,565 shares to a commercial bank in connection with the establishment of a line of credit to High Plains Investments LLC (see note (1)) and 212,415 shares to a commercial bank in connection with a personal loan. In addition to the shares of common stock indicated, Dr. Byrne is the beneficial owner of 63,775 shares of our Blockchain Voting Series A Preferred Stock, which votes with the common stock.

(4)
Ms. Abraham's shares include 6,167 shares issuable under stock-based awards.

(5)
Mr. Corbus' shares include 17,833 shares issuable under stock-based awards.

(6)
Mr. Tobacco's shares include 2,833 shares issuable under stock-based awards.

(7)
Mr. Johnson's shares include 7,500 shares issuable under stock-based awards.

(8)
Dr. Kalyanam's shares include 2,833 shares issuable under stock-based awards.

(9)
Mr. Hughes' shares include 7,500 shares issuable under stock-based awards.

(10)
Mr. Noursalehi's shares include 9,166 shares issuable under stock-based awards.

(11)
At February 10, 2017 Ms. Simon was no longer an employee of the Company. We do not know how many shares, if any, Ms. Simon owned at February 10, 2017. The number shown is the last information we have.

(12)
At February 10, 2017 Mr. Edwards was no longer an employee of the Company. We do not know how many shares, if any, Mr. Edwards owned at February 10, 2017. The number shown is the last information we have.

(13)
At February 10, 2017 Ms. Malaszenko was no longer an employee of the Company.

(14)
At February 10, 2017 Mr. Wilkins was no longer an employee of the Company. We do not know how many shares, if any, Mr. Wilkins owned at February 10, 2017. The number shown is the last information we have.

(15)
Total includes the last information we have for Named Executive Officers who have left the Company and not provided updated information.

        The Company is not aware of any arrangements, including any pledge by any person of securities of the Company, the operation of which may at a subsequent date result in a change in control of the Company.

55


Table of Contents


OTHER INFORMATION

        Since January 1, 2016, there has not been, and there is not currently proposed, any transaction or series of similar transactions requiring disclosure under Item 404 of Regulation S-K except as described below. We compensate our directors and officers as described above.

        From time to time Haverford Valley, L.C., which is an affiliate of ours controlled by our chief executive officer, Patrick M. Byrne, and certain affiliated entities make travel arrangements for our executives and pay the travel-related expenses incurred by our executives on Company business. In 2016, the amount we reimbursed Haverford Valley, L.C. for these expenses was $703,159. Although the amount of these reimbursements in 2017 is unknown, the amount could exceed $120,000. The amounts we pay to Haverford Valley, L.C. as reimbursement of air travel expenses are at estimated commercially available airline rates. The other amounts we reimburse to Haverford Valley, L.C. are reimbursed at its actual cost. Dr. Byrne owns 100% of the equity interest in Haverford Valley, L.C. The amounts paid to Haverford Valley, L.C. are reimbursements of costs incurred on behalf of the Company.

        On November 2, 2016 we entered into a Software Licensing Agreement with SiteHelix Inc. (the "SiteHelix Agreement"). Saum Noursalehi, our President, Retail, is the majority owner of SiteHelix. Pursuant to the SiteHelix Agreement, SiteHelix granted a non-exclusive, non-transferrable license to its proprietary software to us. The software is intended to improve customer conversion rates on our website. Pursuant to the SiteHelix Agreement, we will pay SiteHelix 20% of an amount, if any, intended to reflect the economic benefit of the software to us, as calculated by us. Either party may terminate the SiteHelix Agreement on 30 days' notice to the other party. In addition to this and other termination rights, we may terminate the SiteHelix Agreement immediately at any time if we determine that we can obtain substantially the same services from an unrelated person or entity at a lower cost, or better services from an unrelated person or entity for substantially the same cost. During 2016 we did not pay or accrue any amount for payment to SiteHelix.

        In December 2016, pursuant to the rights offering we made to all of our stockholders, our Chief Executive Officer, Dr. Patrick M. Byrne, purchased 63,775 shares of Series A Preferred from us for $1,000,000. In connection with the rights offering, we entered into a registration rights agreement with Dr. Byrne for his benefit and the benefit of any other affiliates of ours who acquired shares of the Series A Preferred or the Series B Preferred in or after the rights offering.

        From time to time we employ relatives of our Named Executive Officers. During 2016 we paid immediate family members of our Named Executive Officers more than $120,000 as follows:

        We paid Nariman Noursalehi, who is the brother of our President, Retail, Saum Noursalehi, total compensation of $220,510.

        We paid two immediate family members of our Named Executive Officer and former Senior Vice President Mr. Alec Wilkins a total of $377,192, including Ms. Debi Brown, Vice President, who we paid total compensation of $338,470.

        We also paid three immediate family members of our Named Executive Officer and former President Ms. Stormy Simon, a total of $213,092. None of these three employees was paid more than $120,000.

        During 2016 we made severance payments to Ms. Simon as described in the Summary Compensation Table, including a severance payment of $325,000, and in connection with her resignation we accelerated 19,759 restricted stock units she held on September 30, 2016 having a value on that date of $302,708.

56


Table of Contents

        During 2016 we made a severance payment of $273,974 to Mr. Wilkins as described in the Summary Compensation Table.

        On January 17, 2017 we made a severance payment of $254,264 to Ms. Malaszenko as described in the Summary Compensation Table.

        On January 27, 2017 we repurchased 604,229 shares of our common stock from one or more subsidiaries of Fairfax Financial Holdings Limited ("Fairfax") at $16.55 per share, for an aggregate purchase price of $10 million. Prior to the sale of the shares, Fairfax was the beneficial owner of approximately 12.5% of our common stock. The sale reduced Fairfax's beneficial ownership to approximately 10.4% of the Company's common stock.

        We expect to pay one or more relatives of Named Executive Officers more than $120,000 in 2017.

        Please see our discussion under "The Board—Policies and Procedures Regarding Related Party Transactions" for a description of our policies and procedures relating to related party transactions.

        Section 16(a) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), requires our officers and directors, and persons who own more than ten percent (10%) of our common stock, to file certain reports regarding ownership of, and transactions in, our securities with the SEC. Such officers, directors, and 10% stockholders are also required to furnish the Company with copies of all Section 16(a) forms that they file.

        Based solely on a review of reports filed by, and on written representations from, our officers, former officers, directors and 10% stockholders, we believe that during 2016 all of our officers, former officers, directors and 10% stockholders complied with requirements for reporting ownership and changes in ownership of our common stock under Section 16(a) of the Exchange Act except as set forth below.

        During 2013 Fairfax Financial Holdings Limited was a 10% beneficial owner of our common stock. In 2017 Fairfax filed a Form 4 that reported two transactions that occurred in 2013 and that were not reported at that time.

        Except for proposals properly made in accordance with Rule 14a-8 under the Exchange Act and included in the notice of meeting given by or at the direction of the Board of Directors, all proposals of stockholders intended to be presented at the next annual meeting of stockholders of the Company, regardless of whether such proposals are intended to be included in the Company's proxy statement for the next annual meeting of the stockholders of the Company, must satisfy the requirements set forth in the Company's Bylaws. As summarized below, the Bylaws provide that in order for stockholder business to be properly brought before an annual meeting by a stockholder, such stockholder must (i) be a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such business is proposed, only if such beneficial owner was the beneficial owner of shares of the Company) both at the time of giving the notice required by the Bylaws and at the time of the meeting, (ii) be entitled to vote at the meeting, and (iii) have complied with the applicable provisions of the Bylaws as to such business. In addition, such stockholder must have given timely notice of the proposed business and related matters in proper written form to the Corporate Secretary of the Company at the Company's principal executive offices, Attention: Corporate Secretary. Stockholders are not permitted to propose business to be brought before a special meeting of the stockholders.

        To be timely, a stockholder proposal must be received at the Company's principal executive offices not less than 90 days nor more than 120 days prior to the one-year anniversary of the preceding year's

57


Table of Contents

annual meeting. However, if the date of the annual meeting is more than 30 days before or more than sixty 60 days after such anniversary date, notice by the stockholder must be delivered not earlier than the 120th day prior to such annual meeting and not later than the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public disclosure of the date of such annual meeting was first made. Stockholder proposals to be presented at the 2018 annual meeting of stockholders must be received by the Corporate Secretary of the Company at the Company's principal executive offices not earlier than January 9, 2018 nor later than February 8, 2018.

        To be in proper written form, a stockholder's proposal delivered to the Secretary of the Company must set forth as to each matter of business the stockholder intends to bring before the annual meeting the information specified in our Bylaws, including (i) certain information about each Proposing Person (as defined in our Bylaws), (ii) certain information about Disclosable Interests, as defined in our Bylaws and (iii) certain information about the proposed business and related matters as required by our Bylaws. The information provided must also be updated and supplemented under certain circumstances as of the record date for the meeting and as of the date that is ten business days prior to the meeting or any adjournment or postponement of the meeting, all as set forth in the Bylaws, and any such updates and supplements must be delivered to the Secretary of the Company at the Company's principal executive offices by the dates described in the Bylaws.

        Any stockholder proposal intended to be included in the Company's proxy statement for the next annual meeting of stockholders of the Company pursuant to Rule 14a-8 under the Exchange Act must be received at the Company's principal executive offices not later than November 14, 2017. If the date of the annual meeting is moved by more than 30 days from the date contemplated at the time of the previous year's proxy statement, then notice must be received within a reasonable time before the Company begins to print and send its proxy materials. Upon such an occurrence, the Company will publicly announce the deadline for submitting a proposal by means of disclosure in a press release or in a document filed with the SEC.

        The requirements for providing advance notice of stockholder business as summarized above are qualified in their entirety by our Bylaws, which we recommend that you to read in order to comply with the requirements for bringing a proposal. You may contact the Company's Secretary at our principal executive offices for a copy of our current Bylaws, including the relevant provisions regarding the requirements for making stockholder proposals and nominating director candidates, or you may refer to the copy of our Bylaws filed with the SEC on November 9, 2015 as Exhibit 3.2 to our Quarterly Report on Form 10-Q, available at http://www.sec.gov. In addition to the requirements of our Bylaws, each Proposing Person must comply with all applicable requirements of the Exchange Act.

        Stockholders may nominate directors for election at an annual meeting or at a special meeting at which directors are to be elected, provided that the nomination satisfies the requirements set forth in the Company's Bylaws. As summarized below, the Bylaws provide that in order for a stockholder nomination to be properly made, such stockholder must (i) be a stockholder of record (and, with respect to any beneficial owner, if different, on whose behalf such nomination is proposed to be made, only if such beneficial owner was the beneficial owner of shares of the Company) both at the time of giving the notice required by the Bylaws and at the time of the meeting, (ii) be entitled to vote at the meeting, and (iii) have complied with the applicable provisions of the Bylaws as to such nomination. As summarized below, the advance notice provisions require a stockholder to give timely notice of a director nomination in proper written form to the Secretary of the Company at the Company's principal executive offices, Attention: Corporate Secretary.

        For a stockholder to give timely notice of a director nomination for an annual meeting, the notice must be received by the Secretary at the Company's principal executive offices not less than 90 days

58


Table of Contents

nor more than 120 days prior to the one-year anniversary of the preceding year's annual meeting. However, if the date of the annual meeting is more than 30 days before or more than sixty 60 days after such anniversary date, notice by the stockholder must be delivered not earlier than the 120th day prior to such annual meeting and not later than the 90th day prior to such annual meeting or, if later, the 10th day following the day on which public disclosure (as defined in the Bylaws) of the date of such annual meeting was first made. Director nominations to be made at the 2018 annual meeting of stockholders must be received by the Secretary of the Company at the Company's principal executive offices not earlier than January 9, 2018 nor later than February 8, 2018.

        For a stockholder to give timely notice of a director nomination for a special meeting at which directors are to be elected, the notice must be received by the Secretary at the Company's principal executive offices not earlier than the 120th day prior to such special meeting and not later than the 90th day prior to such special meeting or, if later, the 10th day following the day on which public disclosure of the date of such special meeting was first made.

        To be in proper written form, a stockholder's notice to the Secretary of the Company must set forth all of the information required by our Bylaws, including (i) as to each Nominating Person (as defined in our Bylaws) certain information about each Nominating Person, (ii) as to each Nominating Person, certain information about Disclosable Interests, as defined in our Bylaws, and (iii) certain information about each person whom a Nominating Person proposes to nominate for election as a director, as specified in our Bylaws. In addition, the Company may require any proposed nominee to furnish such other information (i) as may reasonably be required by the Company to determine the eligibility of such proposed nominee to serve as an independent director of the Company in accordance with applicable requirements or (ii) that could be material to a reasonable stockholder's understanding of the independence or lack of independence of such proposed nominee. The information provided must also be updated and supplemented under certain circumstances as of the record date for the meeting and as of the date that is ten business days prior to the meeting or any adjournment or postponement of the meeting, all as set forth in the Bylaws, and any such updates and supplements must be delivered to the Secretary of the Company at the Company's principal executive offices by the dates described in the Bylaws. In addition to the requirements of our Bylaws, each Nominating Person must comply with all applicable requirements of the Exchange Act.

        The requirements for providing advance notice of a director nomination as summarized above are qualified in their entirety by our Bylaws, which we recommend that you to read in order to comply with the requirements for making a director nomination.

        The solicitation is made on behalf of the Board of Directors of the Company. We will pay the cost of soliciting these proxies. We will reimburse brokerage houses and other custodians, nominees and fiduciaries for reasonable expenses they incur in sending these proxy materials to you if you are a beneficial holder of our shares.

        Without receiving additional compensation, officials and regular employees of the Company may solicit proxies personally, by telephone, fax or email from stockholders if proxies are not promptly received. We have also retained Georgeson Inc. to assist in the solicitation of proxies at a cost of approximately $9,500 plus out-of-pocket expenses.

        A copy of our 2016 Form 10-K, excluding exhibits, is enclosed with this Proxy Statement. You may obtain an additional copy without charge by sending a written request to Overstock.com, Inc., Attention Investor Relations, 799 W. Coliseum Way, Midvale, Utah 84047. The 2016 Form 10-K is also available on our website at http://www.overstock.com/proxy.

59


Table of Contents

        Stockholders who share an address may receive only a single copy of the proxy statement, notice of internet availability and Form 10-K. This is known as householding. Stockholders who desire either to receive multiple copies of these materials, or to receive only a single copy in the future, should contact their broker or other nominee or, if a stockholder of record, the Company at the address shown below. We will promptly deliver a separate copy of any of these materials to any stockholder who contacts our investor relations department at 799 W. Coliseum Way, Midvale, Utah 84047, or by calling Overstock Investor Relations at (801) 947-3100.

        Stockholders of record residing at the same address and currently receiving multiple copies of the proxy materials may contact our registrar and transfer agent, Computershare Trust Company, N.A. ("Computershare"), to request that only a single copy of the proxy materials be mailed in the future. You may contact Computershare by phone at (877) 373-6374 or by mail at 250 Royall Street, Canton, MA 02021.

    By Order of the Board,
    GRAPHIC
    Jonathan E. Johnson III
Chairman of the Board of Directors

March 14, 2017
Midvale, Utah

60


Table of Contents


OVERSTOCK.COM, INC.

2005 EQUITY INCENTIVE PLAN

(
as proposed to be amended and restated)

        1.    Purposes of the Plan and Limitation on Awards to Non-Employee Directors.    The purposes of this 2005 Equity Incentive Plan are:

        Awards granted under the Plan may be Incentive Stock Options, Nonstatutory Stock Options, Restricted Stock, Restricted Stock Units, Stock Appreciation Rights, Performance Shares, Performance Units or Deferred Stock Units, as determined by the Administrator at the time of grant.

        Awards to any non-employee Director during any Fiscal Year plus the cash fees payable to such Director during such Fiscal Year for service as an non-employee Director shall not exceed $400,000 in total value (calculating the value of any such Awards based on the grant date fair value for financial reporting purposes of such Awards), plus up to an additional $200,000 for service on any special committee of the Board. Consulting fees or other compensation the Company may pay or provide to any non-employee Director for services in addition to the services normally performed by a non-employee Director shall not be included in calculating such limits.

        2.    Definitions.    As used herein, the following definitions shall apply:

A-1


Table of Contents

A-2


Table of Contents

A-3


Table of Contents

A-4


Table of Contents

A-5


Table of Contents

        3.    Stock Subject to the Plan.    Subject to the provisions of Section 16 of the Plan, the maximum aggregate number of Shares which will be available for grant under the Plan after approval by the stockholders at the 2017 annual meeting of stockholders is 1,978,307, less the number of shares, if any, subjected to Awards between February 15, 2017 and the date of the 2017 annual meeting, and increased by the number of Shares, if any, subject to Awards forfeited back to the Plan between February 15, 2017 and the date of the 2017 annual meeting. The Shares may be authorized, but unissued, or reacquired Common Stock. All shares reserved for issuance under this Plan may be used for Incentive Stock Options.

        To the extent that Shares subject to an Award are not issued to a Participant because the Award terminates, expires, lapses or becomes unexercisable without having been exercised in full for any

A-6


Table of Contents

reason, or an Award is settled in cash, or is surrendered pursuant to an Award Exchange Program, or, with respect to Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units or Deferred Stock Units, is forfeited to or repurchased by the Company, the unissued Shares (or for Awards other than Options and SARs, the forfeited or repurchased shares) which were subject thereto shall become available for future grant or sale under the Plan (unless the Plan has terminated). However, the full number of Stock Appreciation Rights granted that are to be settled by the issuance of Shares shall be counted against the number of Shares available for award under the Plan, regardless of the number of Shares actually issued upon settlement of such Stock Appreciation Rights. Shares that have actually been issued under the Plan under any Award shall not be returned to the Plan and shall not become available for future distribution under the Plan. Shares surrendered or withheld in payment of the exercise price of an Option and Shares withheld by the Company to satisfy any minimum tax withholding obligation shall count against the aggregate plan limit described above. To the extent an Award under the Plan is paid out in cash rather than Shares, such cash payment shall not result in a reduction to the number of Shares available for issuance under the Plan. Shares repurchased by the Company on the open market with the proceeds of an Option exercise shall not be added to the number of Shares available for grant under the Plan. No fractional shares of Stock may be issued hereunder.

        4.    Administration of the Plan.    

A-7


Table of Contents

        5.    Eligibility.    Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units, Stock Appreciation Rights, Deferred Stock Units and Nonstatutory Stock Options may be granted to Service Providers. Incentive Stock Options may be granted only to Employees. A Consultant shall not

A-8


Table of Contents

be eligible for the grant of an Award if, at the time of grant, a Form S-8 Registration Statement ("Form S-8") under the Securities Act, is not available to register either the offer or the sale of the Company's securities to such Consultant because of the nature of the services that the Consultant is providing to the Company (i.e., capital raising), or because the Consultant is not a natural person, or as otherwise provided by the rules governing the use of Form S-8, unless the Company determines both (i) that such grant (A) shall be registered in another manner under the Securities Act (e.g., on a Form S-3 Registration Statement) or (B) does not require registration under the Securities Act in order to comply with the requirements of the Securities Act, if applicable, and (ii) that such grant complies with the securities laws of all other relevant jurisdictions.

        6.    No Employment Rights.    Neither the Plan nor any Award shall confer upon a Participant any right with respect to continuing the Participant's employment with the Company or its Subsidiaries, nor shall they interfere in any way with the Participant's right or the Company's or Subsidiary's right, as the case may be, to terminate such employment at any time, with or without cause.

        7.    Code Section 162(m) Provisions.    

A-9


Table of Contents

        8.    Effective Date; Term of Plan.    The Plan's effective date is the date on which it is adopted by the Board, so long as it is approved by the Company's stockholders at any time within 12 months of such adoption. The Plan will have no fixed expiration date; provided, however, that no Incentive Stock Options may be granted more than 10 years after the later of (a) the Plan's adoption by the Board, or (b) the adoption by the Board of any amendment to the Plan that constitutes the adoption of a new plan for purposes of Section 422 of the Code.

        9.    Stock Options.    

A-10


Table of Contents

A-11


Table of Contents

A-12


Table of Contents

        10.    Stock Appreciation Rights.    

A-13


Table of Contents

A-14


Table of Contents

        11.    Restricted Awards.    

A-15


Table of Contents

A-16


Table of Contents

        12.    Performance Shares.    

A-17


Table of Contents

        13.    Performance Units.    

        14.    Deferred Stock Units.    

        15.    Non-Transferability of Awards.    Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent or distribution and may be exercised, during the lifetime of the recipient, only by the recipient. If the Administrator makes an Award transferable, such Award shall contain such additional terms and conditions as the Administrator deems appropriate.

        16.    Adjustments Upon Changes in Capitalization, Dissolution or Liquidation or Change of Control.    

A-18


Table of Contents

A-19


Table of Contents

A-20


Table of Contents

        17.    Date of Grant.    The date of grant of an Award shall be, for all purposes, the date on which the Administrator makes the determination granting such Award, or such other later date as is determined by the Administrator. Notice of the determination shall be provided to each Participant within a reasonable time after the date of such grant.

        18.    Amendment and Termination of the Plan.    

        19.    Conditions Upon Issuance of Shares.    

        20.    Liability of Company.    

A-21


Table of Contents

        21.    General Provisions.    

        22.    Reservation of Shares.    The Company, during the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the requirements of the Plan.

A-22


 

NNNNNNNNNNNN . MMMMMMMMMMMMMMM C123456789 000004 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext 000000000.000000 ext ENDORSEMENT_LINE______________ SACKPACK_____________ Electronic Voting Instructions You can vote by Internet or telephone! Available 24 hours a day, 7 days a week! Instead of mailing your proxy, you may choose one of the two voting methods outlined below to vote your proxy. VALIDATION DETAILS ARE LOCATED BELOW IN THE TITLE BAR If you are a registered stockholder, the deadline for submitting your vote by telephone or via the Internet is 11:59 p.m. Eastern Time on May 8, 2017. If you are a member of a retirement or savings plan or other similar plan, the deadline for submitting your voting directions by telephone or via the Internet is 2:00 a.m. Eastern Time on May 5, 2017. Vote by Internet • Go to www.envisionreports.com/OSTK • Or scan the QR code with your smartphone • Follow the steps outlined on the secure website MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 ADD 5 ADD 6 Vote by telephone • Call toll free 1-800-652-VOTE (8683) within the USA, US territories & Canada on a touch tone telephone • Follow the instructions provided by the recorded message Using a black ink pen, mark your votes with an X as shown in this example. Please do not write outside the designated areas. q IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q Election of Directors — The Board of Directors recommends a vote FOR all the nominees listed (terms to expire at the 2020 annual stockholder meeting). + 1. Election of Class III Directors: 01 - Allison H. Abraham For Withhold For Withhold 02 - Saum Noursalehi Proposals — The Board of Directors recommends a vote FOR Proposals 2, 3 and 4 and a vote for THREE YEARS on Proposal 5. For Against Abstain ForAgainst Abstain 2. To ratify the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017. 4. Advisory vote to approve executive officer compensation. 3. Approval of amendment and restatement of the Company’s equity incentive plan. For Against Abstain 1 Year 2 Years 3 Years Abstain 5. Advisory vote on the frequency of future advisory votes on executive officer compensation. 6. To consider and act upon any other matter properly coming before the annual meeting. Authorized Signatures — This section must be completed for your vote to be counted. — Date and Sign Below Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. Date (mm/dd/yyyy) — Please print date below. Signature 1 — Please keep signature within the box. Signature 2 — Please keep signature within the box. NNNNNDNecembeNr 31, 2016 are available at http://www.overstock.com/proxy. IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A - D ON BOTH SIDES OF THIS CARD. C 1234567890 J N T MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE 140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND + MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND 1 P C F3 1 9 0 6 2 1 MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND 02JJVD NNNNNNNNN IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 9, 2017 The Notice of Annual Meeting, Proxy Statement, and Annual Report on Form 10-K for the fiscal year ended C B A Annual Meeting Proxy Card1234 5678 9012 345 X IMPORTANT ANNUAL MEETING INFORMATION

 


. ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards, annual reports and notices of availability electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. q IF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q Proxy/Voting Instructions — Overstock.com, Inc. Annual Stockholder Meeting — May 9, 2017 + PROXY SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS — ANNUAL MEETING The undersigned, having received the Proxy Statement and Notice of Annual Meeting, each dated March 14, 2017, hereby appoints Patrick M. Byrne and Jonathan E. Johnson III, or either of them, as proxies and attorneys-in-fact, each with full power of substitution and re-substitution, to represent the undersigned at the Annual Meeting of Stockholders of Overstock.com, Inc. (the “Company”) to be held at the offices of Overstock.com, located at 799 W. Coliseum Way, Midvale, Utah, at 1:00 p.m. Mountain Time on May 9, 2017, including any adjournments or postponements thereof, and to vote the number of shares the undersigned would be entitled to vote if personally present at the meeting, including all shares of common stock, Blockchain Voting Series A Preferred Stock and Voting Series B Preferred Stock, on all matters, including the election of any person to the Board in place of any nominee who is unable to serve or for good cause will not serve. IF NO DIRECTION IS GIVEN, THIS PROXY WILL BE VOTED FOR THE NOMINEES LISTED IN PROPOSAL 1, FOR PROPOSALS 2, 3 AND 4, AND FOR THREE YEARS ON PROPOSAL 5. IF SPECIFIC INSTRUCTIONS ARE INDICATED, THIS PROXY WILL BE VOTED IN ACCORDANCE WITH THOSE INSTRUCTIONS. IN THEIR DISCRETION, THE PROXIES ARE AUTHORIZED TO VOTE UPON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING. If the undersigned is a participant in the Overstock.com, Inc. 401(k) Plan, the undersigned hereby instructs the fiduciary of the Overstock.com, Inc. 401(k) Plan to vote, as designated on the reverse side, all shares of Overstock.com, Inc. that are credited to the account(s) of the undersigned (whether vested or not) in the 401(k) Plan at the Annual Meeting of Stockholders to be held on May 9, 2017 and at any adjournment or postponement thereof. If no voting instructions are given, the Administrator of the 401(k) plan, which is composed of members of the Board of Directors and/or management personnel, may instruct the fiduciary to vote the shares. PLEASE COMPLETE, DATE AND SIGN THIS PROXY/VOTING INSTRUCTIONS ON THE OTHER SIDE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. Non-Voting Items Change of Address — Please print your new address below. Comments — Please print your comments below. Meeting Attendance Mark the box to the right if you plan to attend the Annual Meeting in person. + IF VOTING BY MAIL, YOU MUST COMPLETE SECTIONS A - D ON BOTH SIDES OF THIS CARD. D